https://pharmaceuticsconference.com/cpd-accreditation 0.9 https://pharmaceuticsconference.com/ 1.0 https://pharmaceuticsconference.com/program/scientific-sessions 0.9 https://pharmaceuticsconference.com/information/venue 0.9 https://pharmaceuticsconference.com/information/accommodation 0.9 https://pharmaceuticsconference.com/information/guidelines 0.9 https://pharmaceuticsconference.com/information/important-dates 0.9 https://pharmaceuticsconference.com/information/faq 0.9 https://pharmaceuticsconference.com/information/conference-brochure 0.9 https://pharmaceuticsconference.com/information/welcome-message 0.9 https://pharmaceuticsconference.com/information/sponsors-exhibitors 0.9 https://pharmaceuticsconference.com/about/past-events 0.9 https://pharmaceuticsconference.com/about/about-organizer 0.9 https://pharmaceuticsconference.com/about/testimonials-reviews 0.9 https://pharmaceuticsconference.com/contact 0.9 https://pharmaceuticsconference.com/submit-abstract 0.9 https://pharmaceuticsconference.com/register 0.9 https://pharmaceuticsconference.com/general-information 0.9 https://pharmaceuticsconference.com/privacy-policy 0.9 https://pharmaceuticsconference.com/terms-and-conditions 0.9 https://pharmaceuticsconference.com/video-gallery 0.9 https://pharmaceuticsconference.com/gallery 0.9 https://pharmaceuticsconference.com/scientific-committee/2026 0.8 https://pharmaceuticsconference.com/scientific-committee/2025 0.8 https://pharmaceuticsconference.com/scientific-committee/2024 0.8 https://pharmaceuticsconference.com/scientific-committee/2023 0.8 https://pharmaceuticsconference.com/scientific-committee/2022 0.8 https://pharmaceuticsconference.com/scientific-committee/2021 0.8 https://pharmaceuticsconference.com/scientific-committee/2020 0.8 https://pharmaceuticsconference.com/scientific-committee/2019 0.8 https://pharmaceuticsconference.com/scientific-committee/2018 0.8 https://pharmaceuticsconference.com/scientific-committee/2017 0.8 https://pharmaceuticsconference.com/speakers/2026 2026-05-27 0.8 https://pharmaceuticsconference.com/speakers/2025 0.8 https://pharmaceuticsconference.com/speakers/2024 0.8 https://pharmaceuticsconference.com/speakers/2023 0.8 https://pharmaceuticsconference.com/speakers/2022 0.8 https://pharmaceuticsconference.com/speakers/2021 0.8 https://pharmaceuticsconference.com/speakers/2020 0.8 https://pharmaceuticsconference.com/speakers/2019 0.8 https://pharmaceuticsconference.com/speakers/2018 0.8 https://pharmaceuticsconference.com/speakers/2017 0.8 https://pharmaceuticsconference.com/speaker/lan-wang 0.8 https://pharmaceuticsconference.com/speaker/tanuja-tummala 0.8 https://pharmaceuticsconference.com/speaker/aadya-daga 0.8 https://pharmaceuticsconference.com/speaker/sareena-naganand 0.8 https://pharmaceuticsconference.com/speaker/adriana-gambardella 0.8 https://pharmaceuticsconference.com/speaker/tayyba-tariq 0.8 https://pharmaceuticsconference.com/speaker/muriel-blanzat 0.8 https://pharmaceuticsconference.com/speaker/kunal-sharma 0.8 https://pharmaceuticsconference.com/speaker/elika-valehi 0.8 https://pharmaceuticsconference.com/speaker/mila-radan 0.8 https://pharmaceuticsconference.com/speaker/lucas-amaral-machado 0.8 https://pharmaceuticsconference.com/speaker/ignacia-paz-torres-fredes 0.8 https://pharmaceuticsconference.com/speaker/ceren-aytar 0.8 https://pharmaceuticsconference.com/speaker/liu-yan 0.8 https://pharmaceuticsconference.com/speaker/dake-chu 0.8 https://pharmaceuticsconference.com/speaker/zhibing-wu 0.8 https://pharmaceuticsconference.com/speaker/chang-ren 0.8 https://pharmaceuticsconference.com/speaker/manpreet-singh 0.8 https://pharmaceuticsconference.com/speaker/priyanka-chaturvedi 0.8 https://pharmaceuticsconference.com/speaker/nihal-singh 0.8 https://pharmaceuticsconference.com/speaker/niyati-shah 0.8 https://pharmaceuticsconference.com/speaker/rama-rao-nadendla 0.8 https://pharmaceuticsconference.com/speaker/abhinav-mehta 0.8 https://pharmaceuticsconference.com/speaker/charu-misra 0.8 https://pharmaceuticsconference.com/speaker/rahul-kumar-gupta 0.8 https://pharmaceuticsconference.com/speaker/bhupendra-g-prajapati 0.8 https://pharmaceuticsconference.com/speaker/hitasha-vithalani 0.8 https://pharmaceuticsconference.com/speaker/swati-sharma 0.8 https://pharmaceuticsconference.com/speaker/shaijan-yakub-shaikh 0.8 https://pharmaceuticsconference.com/speaker/aghapy-yermans-yakoup 0.8 https://pharmaceuticsconference.com/speaker/jamshed-hashim 0.8 https://pharmaceuticsconference.com/speaker/homer-nogue 0.8 https://pharmaceuticsconference.com/speaker/azza-dawoud-h-dawoud 0.8 https://pharmaceuticsconference.com/speaker/susumu-hama 0.8 https://pharmaceuticsconference.com/speaker/fulwah-yahya-alqahtani 0.8 https://pharmaceuticsconference.com/speaker/fadilah-sfouq-aleanizy 0.8 https://pharmaceuticsconference.com/speaker/bushra-t-alquadeib 0.8 https://pharmaceuticsconference.com/speaker/lubna-y-ashri 0.8 https://pharmaceuticsconference.com/speaker/shubham-singh 0.8 https://pharmaceuticsconference.com/speaker/prasanta-bera 0.8 https://pharmaceuticsconference.com/speaker/aastha-thakur 0.8 https://pharmaceuticsconference.com/speaker/pradeepa-prasad 0.8 https://pharmaceuticsconference.com/speaker/divya 0.8 https://pharmaceuticsconference.com/speaker/alaa-alkaram 0.8 https://pharmaceuticsconference.com/speaker/benhaddou-a-i 0.8 https://pharmaceuticsconference.com/speaker/souad-benaouf 0.8 https://pharmaceuticsconference.com/speaker/sobhan-yousefi 0.8 https://pharmaceuticsconference.com/speaker/vladlen-slepak 0.8 https://pharmaceuticsconference.com/speaker/yong-xiao-wang 0.8 https://pharmaceuticsconference.com/speaker/paulo-cesar-de-morais 0.8 https://pharmaceuticsconference.com/speaker/huiqin-yang 0.8 https://pharmaceuticsconference.com/speaker/stephen-hsu 0.8 https://pharmaceuticsconference.com/speaker/phanikumar-reddy-satti 0.8 https://pharmaceuticsconference.com/speaker/dominic-sandell 0.8 https://pharmaceuticsconference.com/speaker/xiaodong-li 0.8 https://pharmaceuticsconference.com/speaker/punam-kumari 0.8 https://pharmaceuticsconference.com/speaker/nurul-ain-binti-mohammad-hamdi 0.8 https://pharmaceuticsconference.com/speaker/lisa-marinelli 0.8 https://pharmaceuticsconference.com/speaker/marilisa-pia-dimmito 0.8 https://pharmaceuticsconference.com/speaker/iria-naveira-souto 0.8 https://pharmaceuticsconference.com/speaker/krisztian-pamlenyi 0.8 https://pharmaceuticsconference.com/speaker/marzena-kaliszewska-kozak 0.8 https://pharmaceuticsconference.com/speaker/mateusz-mlynek 0.8 https://pharmaceuticsconference.com/speaker/michal-szkop 0.8 https://pharmaceuticsconference.com/speaker/julia-macyszyn 0.8 https://pharmaceuticsconference.com/speaker/weronika-leszczynska 0.8 https://pharmaceuticsconference.com/speaker/sigal-fleisher-berkovich 0.8 https://pharmaceuticsconference.com/speaker/maria-jose-de-rosa 0.8 https://pharmaceuticsconference.com/speaker/regina-gomes-dare 0.8 https://pharmaceuticsconference.com/speaker/mizuho-sumitani 0.8 https://pharmaceuticsconference.com/speaker/waleed-mohammed-al-shaqha 0.8 https://pharmaceuticsconference.com/speaker/rukiye-oztekin 0.8 https://pharmaceuticsconference.com/speaker/r-k-maheshwari 0.8 https://pharmaceuticsconference.com/speaker/parikshit-r-shirode 0.8 https://pharmaceuticsconference.com/speaker/bindiya-chauhan 0.8 https://pharmaceuticsconference.com/speaker/nilay-solanki 0.8 https://pharmaceuticsconference.com/speaker/anil-pareek 0.8 https://pharmaceuticsconference.com/speaker/prashant-bhokardankar 0.8 https://pharmaceuticsconference.com/speaker/monica-arora 0.8 https://pharmaceuticsconference.com/speaker/mst-rozina-parul 0.8 https://pharmaceuticsconference.com/speaker/meliha-mehic 0.8 https://pharmaceuticsconference.com/speaker/nizama-hodzic 0.8 https://pharmaceuticsconference.com/speaker/roman-lysiuk 0.8 https://pharmaceuticsconference.com/speaker/elena-donici 0.8 https://pharmaceuticsconference.com/speaker/iulia-bozbei 0.8 https://pharmaceuticsconference.com/speaker/boutheina-ben-abdelmoumen-mardassi 0.8 https://pharmaceuticsconference.com/speaker/consolata-nsanzubuhoro 0.8 https://pharmaceuticsconference.com/speaker/rose-stiffin 0.8 https://pharmaceuticsconference.com/speaker/sergey-suchkov 0.8 https://pharmaceuticsconference.com/speaker/consolato-m-sergi 0.8 https://pharmaceuticsconference.com/speaker/bruce-daugherty 0.8 https://pharmaceuticsconference.com/speaker/priya-hays 0.8 https://pharmaceuticsconference.com/speaker/maria-cristina-gamberini 0.8 https://pharmaceuticsconference.com/speaker/shripriya-kalbhavi 0.8 https://pharmaceuticsconference.com/speaker/riyadh-al-asady 0.8 https://pharmaceuticsconference.com/speaker/fatma-haddad 0.8 https://pharmaceuticsconference.com/speaker/bernd-blobel 0.8 https://pharmaceuticsconference.com/speaker/rassa-pegahi 0.8 https://pharmaceuticsconference.com/speaker/thomas-ullrich 0.8 https://pharmaceuticsconference.com/speaker/barbara-de-filippis 0.8 https://pharmaceuticsconference.com/speaker/fatemeh-ahmadvand 0.8 https://pharmaceuticsconference.com/speaker/anders-b-christensen 0.8 https://pharmaceuticsconference.com/speaker/yuna-tatsumi 0.8 https://pharmaceuticsconference.com/speaker/yusuke-shimoyama 0.8 https://pharmaceuticsconference.com/speaker/afonin-s-m 0.8 https://pharmaceuticsconference.com/speaker/elisabetta-stretti 0.8 https://pharmaceuticsconference.com/speaker/stella-kafkala 0.8 https://pharmaceuticsconference.com/speaker/panagiotis-mallis 0.8 https://pharmaceuticsconference.com/speaker/dasharath-muljibhai-patel 0.8 https://pharmaceuticsconference.com/speaker/pratip-kashinath-chaskar 0.8 https://pharmaceuticsconference.com/speaker/raja-chakraverty 0.8 https://pharmaceuticsconference.com/speaker/dharmendra-kumar 0.8 https://pharmaceuticsconference.com/speaker/deepika-sharma 0.8 https://pharmaceuticsconference.com/speaker/abhay-tharmatt 0.8 https://pharmaceuticsconference.com/speaker/asish-bhaumik 0.8 https://pharmaceuticsconference.com/speaker/rayhan-shahid-shanavas 0.8 https://pharmaceuticsconference.com/speaker/ayse-nur-oktay 0.8 https://pharmaceuticsconference.com/speaker/alper-onder 0.8 https://pharmaceuticsconference.com/speaker/muhammed-tilahun-muhammed 0.8 https://pharmaceuticsconference.com/speaker/ibrahim-a-al-othaim 0.8 https://pharmaceuticsconference.com/speaker/shu-chun-liu 0.8 https://pharmaceuticsconference.com/speaker/mutaz-s-salem 0.8 https://pharmaceuticsconference.com/speaker/shereen-m-assaf 0.8 https://pharmaceuticsconference.com/speaker/siobhan-fogarty 0.8 https://pharmaceuticsconference.com/speaker/vyacheslav-r-shulunov 0.8 https://pharmaceuticsconference.com/speaker/savvopoulos-pantelis 0.8 https://pharmaceuticsconference.com/speaker/benahmed-nacira 0.8 https://pharmaceuticsconference.com/speaker/john-k-maesaka 0.8 https://pharmaceuticsconference.com/speaker/wayne-kaesemeyer 0.8 https://pharmaceuticsconference.com/speaker/andreas-m-papas 0.8 https://pharmaceuticsconference.com/speaker/richard-z-cheng 0.8 https://pharmaceuticsconference.com/speaker/mario-souza-y-machorro 0.8 https://pharmaceuticsconference.com/speaker/andrea-stierle 0.8 https://pharmaceuticsconference.com/speaker/ravi-p-sahu 0.8 https://pharmaceuticsconference.com/speaker/gurpreet-singh 0.8 https://pharmaceuticsconference.com/speaker/maria-borrell 0.8 https://pharmaceuticsconference.com/speaker/noemi-rotllan-vila 0.8 https://pharmaceuticsconference.com/speaker/franz-josef-meyer-almes 0.8 https://pharmaceuticsconference.com/speaker/richard-denk 0.8 https://pharmaceuticsconference.com/speaker/thomas-j-webster 0.8 https://pharmaceuticsconference.com/speaker/andreia-freitas 0.8 https://pharmaceuticsconference.com/speaker/anna-w-sobanska 0.8 https://pharmaceuticsconference.com/speaker/danuta-drozdowska 0.8 https://pharmaceuticsconference.com/speaker/saad-tayyab 0.8 https://pharmaceuticsconference.com/speaker/nikola-matejkova 0.8 https://pharmaceuticsconference.com/speaker/mujde-eryilmaz 0.8 https://pharmaceuticsconference.com/speaker/aysu-selcuk 0.8 https://pharmaceuticsconference.com/speaker/ali-yetgin 0.8 https://pharmaceuticsconference.com/speaker/zinnet-evval-aksoyalp 0.8 https://pharmaceuticsconference.com/speaker/kalirajan-rajagopal 0.8 https://pharmaceuticsconference.com/speaker/asit-kumar-chakraborty 0.8 https://pharmaceuticsconference.com/speaker/suresh-p-k 0.8 https://pharmaceuticsconference.com/speaker/geetanjali-sageena 0.8 https://pharmaceuticsconference.com/speaker/ashtavaidyan-dr-e-t-krishnan-mooss 0.8 https://pharmaceuticsconference.com/speaker/rajesh-kumar 0.8 https://pharmaceuticsconference.com/speaker/rudra-pratap-singh-rajput 0.8 https://pharmaceuticsconference.com/speaker/juan-gu 0.8 https://pharmaceuticsconference.com/speaker/eman-ramadan-abbase 0.8 https://pharmaceuticsconference.com/speaker/delia-teresa-sponza 0.8 https://pharmaceuticsconference.com/speaker/alena-korbut 0.8 https://pharmaceuticsconference.com/speaker/axel-h-schonthal 0.8 https://pharmaceuticsconference.com/speaker/ruchika-bajaj 0.8 https://pharmaceuticsconference.com/speaker/fanfei-meng 0.8 https://pharmaceuticsconference.com/speaker/victoria-demina 0.8 https://pharmaceuticsconference.com/speaker/samir-haddouchi 0.8 https://pharmaceuticsconference.com/speaker/liberata-sportiello 0.8 https://pharmaceuticsconference.com/speaker/roberto-visentin 0.8 https://pharmaceuticsconference.com/speaker/joanna-cha-upka 0.8 https://pharmaceuticsconference.com/speaker/adam-sikora 0.8 https://pharmaceuticsconference.com/speaker/cornelia-braicu 0.8 https://pharmaceuticsconference.com/speaker/mihaela-ileana-ionescu 0.8 https://pharmaceuticsconference.com/speaker/mirjana-b-colovic 0.8 https://pharmaceuticsconference.com/speaker/miroslav-radenkovic 0.8 https://pharmaceuticsconference.com/speaker/ekaterina-pashkina 0.8 https://pharmaceuticsconference.com/speaker/aysu-yurdasiper 0.8 https://pharmaceuticsconference.com/speaker/hilal-erdogan 0.8 https://pharmaceuticsconference.com/speaker/merita-kucuku 0.8 https://pharmaceuticsconference.com/speaker/mia-karam 0.8 https://pharmaceuticsconference.com/speaker/gil-goncalves 0.8 https://pharmaceuticsconference.com/speaker/essa-abdullah-aldulaym 0.8 https://pharmaceuticsconference.com/speaker/ibrahim-a-alsarra 0.8 https://pharmaceuticsconference.com/speaker/andre-luiz-pereira 0.8 https://pharmaceuticsconference.com/speaker/amira-zaky 0.8 https://pharmaceuticsconference.com/speaker/tarek-aboul-fadl 0.8 https://pharmaceuticsconference.com/speaker/mohammad-arshad 0.8 https://pharmaceuticsconference.com/speaker/heema-desai 0.8 https://pharmaceuticsconference.com/speaker/tanvi-s-kabre 0.8 https://pharmaceuticsconference.com/speaker/nikita-kale 0.8 https://pharmaceuticsconference.com/speaker/prateeti-chakraborty 0.8 https://pharmaceuticsconference.com/speaker/maimuna-fatima 0.8 https://pharmaceuticsconference.com/speaker/neha-agarwal 0.8 https://pharmaceuticsconference.com/speaker/shiv-kumar 0.8 https://pharmaceuticsconference.com/speaker/rakhi-mishra 0.8 https://pharmaceuticsconference.com/speaker/divya-sharma 0.8 https://pharmaceuticsconference.com/speaker/khagga-bhavyasri 0.8 https://pharmaceuticsconference.com/speaker/deepika-raina 0.8 https://pharmaceuticsconference.com/speaker/deepinder-singh 0.8 https://pharmaceuticsconference.com/speaker/keerti-maheshwari 0.8 https://pharmaceuticsconference.com/speaker/prerna-sharma 0.8 https://pharmaceuticsconference.com/speaker/eman-a-alam 0.8 https://pharmaceuticsconference.com/speaker/marino-nebuloni 0.8 https://pharmaceuticsconference.com/speaker/francesca-selmin 0.8 https://pharmaceuticsconference.com/speaker/zoltan-banoczi 0.8 https://pharmaceuticsconference.com/speaker/abhishek-gupta 0.8 https://pharmaceuticsconference.com/speaker/leo-k-iwai 0.8 https://pharmaceuticsconference.com/speaker/janice-mani 0.8 https://pharmaceuticsconference.com/speaker/monika-stanciauskaite 0.8 https://pharmaceuticsconference.com/speaker/florin-borcan 0.8 https://pharmaceuticsconference.com/speaker/ozge-esim 0.8 https://pharmaceuticsconference.com/speaker/katarina-kores 0.8 https://pharmaceuticsconference.com/speaker/nada-f-abo-el-magd 0.8 https://pharmaceuticsconference.com/speaker/sawsan-zaitone 0.8 https://pharmaceuticsconference.com/speaker/md-abdur-rashid 0.8 https://pharmaceuticsconference.com/speaker/armorel-diane-van-eyk 0.8 https://pharmaceuticsconference.com/speaker/mansureh-ghavamm 0.8 https://pharmaceuticsconference.com/speaker/bhupendra-gopalbhai-prajapati 0.8 https://pharmaceuticsconference.com/speaker/hector-m-alvarez 0.8 https://pharmaceuticsconference.com/speaker/daniela-monti 0.8 https://pharmaceuticsconference.com/speaker/carlos-j-c-rodrigues 0.8 https://pharmaceuticsconference.com/speaker/siguna-mueller 0.8 https://pharmaceuticsconference.com/speaker/mohammed-amine-serghini 0.8 https://pharmaceuticsconference.com/speaker/shyamapada-mandal 0.8 https://pharmaceuticsconference.com/speaker/victor-alfonso-alonso-campos 0.8 https://pharmaceuticsconference.com/speaker/itzel-covarrubias-garcia 0.8 https://pharmaceuticsconference.com/speaker/dmitry-ustyuzhanin 0.8 https://pharmaceuticsconference.com/speaker/mansureh-ghavam 0.8 https://pharmaceuticsconference.com/speaker/rohit-bhatia 0.8 https://pharmaceuticsconference.com/speaker/medina-pino-l-m 0.8 https://pharmaceuticsconference.com/speaker/mohamad-abadelah 0.8 https://pharmaceuticsconference.com/speaker/robert-houlden 0.8 https://pharmaceuticsconference.com/speaker/robert-p-bianchi 0.8 https://pharmaceuticsconference.com/speaker/ann-mari-holsaeter 0.8 https://pharmaceuticsconference.com/speaker/jan-tavernier 0.8 https://pharmaceuticsconference.com/speaker/fabien-gosselet 0.8 https://pharmaceuticsconference.com/speaker/kazem-alemzadeh 0.8 https://pharmaceuticsconference.com/speaker/rafael-vazquez-duhalt 0.8 https://pharmaceuticsconference.com/speaker/shun-ichiro-taniguchi 0.8 https://pharmaceuticsconference.com/speaker/ylenia-zambito 0.8 https://pharmaceuticsconference.com/speaker/chie-watanabe 0.8 https://pharmaceuticsconference.com/speaker/nikolay-e-polyakov 0.8 https://pharmaceuticsconference.com/speaker/gulcin-arslan-azizoglu 0.8 https://pharmaceuticsconference.com/speaker/enkelejda-goci 0.8 https://pharmaceuticsconference.com/speaker/paritosh-pande 0.8 https://pharmaceuticsconference.com/speaker/shayan-fakhraei-lahiji 0.8 https://pharmaceuticsconference.com/speaker/aditya-tatavart 0.8 https://pharmaceuticsconference.com/speaker/yoko-matsumoto 0.8 https://pharmaceuticsconference.com/speaker/angelita-rebollo 0.8 https://pharmaceuticsconference.com/speaker/rui-tamura 0.8 https://pharmaceuticsconference.com/speaker/marianne-parent 0.8 https://pharmaceuticsconference.com/speaker/toussaint-bertrand 0.8 https://pharmaceuticsconference.com/speaker/elinaz-farokhi 0.8 https://pharmaceuticsconference.com/speaker/jaunius-urbonavi-ius 0.8 https://pharmaceuticsconference.com/speaker/silvia-tampucci 0.8 https://pharmaceuticsconference.com/speaker/juliette-vergnaud-gauduchon 0.8 https://pharmaceuticsconference.com/speaker/nokyoung-park 0.8 https://pharmaceuticsconference.com/speaker/haissam-abou-saleh 0.8 https://pharmaceuticsconference.com/speaker/justine-fraser 0.8 https://pharmaceuticsconference.com/speaker/farzin-roohvand 0.8 https://pharmaceuticsconference.com/speaker/razan-ghattas-mhanna 0.8 https://pharmaceuticsconference.com/speaker/vladimir-a-d-yakonov 0.8 https://pharmaceuticsconference.com/speaker/gulnihal-ozcan 0.8 https://pharmaceuticsconference.com/speaker/marlene-l-cio 0.8 https://pharmaceuticsconference.com/speaker/eliana-silva-de-moraes 0.8 https://pharmaceuticsconference.com/speaker/satoshi-nakata 0.8 https://pharmaceuticsconference.com/speaker/amanda-silva-brun 0.8 https://pharmaceuticsconference.com/speaker/adley-antonini-neves-de-lima 0.8 https://pharmaceuticsconference.com/speaker/maria-van-dongen 0.8 https://pharmaceuticsconference.com/speaker/nathalie-janel 0.8 https://pharmaceuticsconference.com/speaker/benfang-helen-ruan 0.8 https://pharmaceuticsconference.com/speaker/mamuka-kvaratskhelia 0.8 https://pharmaceuticsconference.com/speaker/roberto-diaz-torres 0.8 https://pharmaceuticsconference.com/speaker/fang-wu 0.8 https://pharmaceuticsconference.com/speaker/samantha-meyer 0.8 https://pharmaceuticsconference.com/speaker/preeti-sharma 0.8 https://pharmaceuticsconference.com/speaker/agris-auce 0.8 https://pharmaceuticsconference.com/speaker/tam-s-jord-n 0.8 https://pharmaceuticsconference.com/speaker/manuela-calin 0.8 https://pharmaceuticsconference.com/speaker/kevin-matzick 0.8 https://pharmaceuticsconference.com/speaker/azra-memon 0.8 https://pharmaceuticsconference.com/speaker/jing-yu 0.8 https://pharmaceuticsconference.com/speaker/pasqualina-liana-scognamiglio 0.8 https://pharmaceuticsconference.com/speaker/hee-kyung-jin 0.8 https://pharmaceuticsconference.com/speaker/antonio-laghezza 0.8 https://pharmaceuticsconference.com/speaker/bartolome-ribas-ozonas 0.8 https://pharmaceuticsconference.com/speaker/hong-yu-li 0.8 https://pharmaceuticsconference.com/speaker/dinesh-kumar-chellappan 0.8 https://pharmaceuticsconference.com/speaker/azeez-yusuf 0.8 https://pharmaceuticsconference.com/speaker/jiyon-lee 0.8 https://pharmaceuticsconference.com/speaker/jos-eduardo-cu-llar 0.8 https://pharmaceuticsconference.com/speaker/barbora-slez-kov 0.8 https://pharmaceuticsconference.com/speaker/eran-lavy 0.8 https://pharmaceuticsconference.com/speaker/subrat-kumar-bhattamisra 0.8 https://pharmaceuticsconference.com/speaker/haeil-park 0.8 https://pharmaceuticsconference.com/speaker/aneka-klavina 0.8 https://pharmaceuticsconference.com/speaker/ahlam-zaid-alkilani 0.8 https://pharmaceuticsconference.com/speaker/rania-hamed 0.8 https://pharmaceuticsconference.com/speaker/areumi-park 0.8 https://pharmaceuticsconference.com/speaker/soo-jin-heo 0.8 https://pharmaceuticsconference.com/speaker/eun-a-kim 0.8 https://pharmaceuticsconference.com/speaker/ekaterina-sobich 0.8 https://pharmaceuticsconference.com/speaker/charlotte-lombardi 0.8 https://pharmaceuticsconference.com/speaker/mervin-meyer 0.8 https://pharmaceuticsconference.com/speaker/geraldine-mayeux 0.8 https://pharmaceuticsconference.com/speaker/concepci-n-renedo-laguna 0.8 https://pharmaceuticsconference.com/speaker/vladimir-p-torchilin 0.8 https://pharmaceuticsconference.com/speaker/vladimir-muzykantov 0.8 https://pharmaceuticsconference.com/speaker/joe-e-springer 0.8 https://pharmaceuticsconference.com/speaker/biana-godin 0.8 https://pharmaceuticsconference.com/speaker/chaodong-wu 0.8 https://pharmaceuticsconference.com/speaker/irina-ermolina 0.8 https://pharmaceuticsconference.com/speaker/ursula-thevarajah 0.8 https://pharmaceuticsconference.com/speaker/gerhard-winter 0.8 https://pharmaceuticsconference.com/speaker/daniel-zucker 0.8 https://pharmaceuticsconference.com/speaker/ilya-yakavets 0.8 https://pharmaceuticsconference.com/speaker/selene-baschieri 0.8 https://pharmaceuticsconference.com/speaker/nataliya-storozhylova 0.8 https://pharmaceuticsconference.com/speaker/hadrien-calmet 0.8 https://pharmaceuticsconference.com/speaker/natassa-pippa 0.8 https://pharmaceuticsconference.com/speaker/marc-du-jardin 0.8 https://pharmaceuticsconference.com/speaker/matej-dobravc-verbic 0.8 https://pharmaceuticsconference.com/speaker/tomasz-osmalek 0.8 https://pharmaceuticsconference.com/speaker/marcelle-machluf 0.8 https://pharmaceuticsconference.com/speaker/elaine-frances-enright 0.8 https://pharmaceuticsconference.com/speaker/maya-bar-zeev 0.8 https://pharmaceuticsconference.com/speaker/takahisa-yamamoto 0.8 https://pharmaceuticsconference.com/speaker/sergey-bachurin 0.8 https://pharmaceuticsconference.com/speaker/yulia-svenskaya 0.8 https://pharmaceuticsconference.com/speaker/k-v-r-n-s-ramesh 0.8 https://pharmaceuticsconference.com/speaker/enise-ece-gurdal 0.8 https://pharmaceuticsconference.com/speaker/luis-jesus-villarreal-gomez 0.8 https://pharmaceuticsconference.com/speaker/lourdes-amable-vega-rasgado 0.8 https://pharmaceuticsconference.com/speaker/guo-ping-zhou 0.8 https://pharmaceuticsconference.com/speaker/ali-dehshahri 0.8 https://pharmaceuticsconference.com/speaker/mehrdad-azarmi-aghajan 0.8 https://pharmaceuticsconference.com/speaker/hassan-saeiahan 0.8 https://pharmaceuticsconference.com/speaker/mario-jug 0.8 https://pharmaceuticsconference.com/speaker/michal-abrahamowicz 0.8 https://pharmaceuticsconference.com/speaker/faiza-naseer 0.8 https://pharmaceuticsconference.com/speaker/gerald-h-tomkin 0.8 https://pharmaceuticsconference.com/speaker/attila-gacsi 0.8 https://pharmaceuticsconference.com/speaker/monika-eniko-balint 0.8 https://pharmaceuticsconference.com/speaker/pawel-brzuzan 0.8 https://pharmaceuticsconference.com/speaker/joanna-jaworska 0.8 https://pharmaceuticsconference.com/speaker/katarzyna-jelonek 0.8 https://pharmaceuticsconference.com/speaker/marcelo-nacucchio 0.8 https://pharmaceuticsconference.com/speaker/mikhail-v-khvostov 0.8 https://pharmaceuticsconference.com/speaker/tatyana-v-leshina 0.8 https://pharmaceuticsconference.com/speaker/jeong-kyu-bang 0.8 https://pharmaceuticsconference.com/speaker/hyung-jun-ahn 0.8 https://pharmaceuticsconference.com/speaker/sang-keun-ha 0.8 https://pharmaceuticsconference.com/speaker/hemant-k-s-yadav 0.8 https://pharmaceuticsconference.com/speaker/lonchin-suguna 0.8 https://pharmaceuticsconference.com/speaker/prashant-g-upadhaya 0.8 https://pharmaceuticsconference.com/speaker/anayanti-arianto 0.8 https://pharmaceuticsconference.com/speaker/ivana-hrebickova 0.8 https://pharmaceuticsconference.com/speaker/hakim-bangun 0.8 https://pharmaceuticsconference.com/speaker/esmaiel-jabbari 0.8 https://pharmaceuticsconference.com/speaker/gus-r-rosania 0.8 https://pharmaceuticsconference.com/speaker/teruna-j-siahaan 0.8 https://pharmaceuticsconference.com/speaker/valery-a-petrenko 0.8 https://pharmaceuticsconference.com/speaker/carmen-popescu 0.8 https://pharmaceuticsconference.com/speaker/andras-g-lacko 0.8 https://pharmaceuticsconference.com/speaker/teresa-carvajal 0.8 https://pharmaceuticsconference.com/speaker/eugenia-v-gurevich 0.8 https://pharmaceuticsconference.com/speaker/huan-xie 0.8 https://pharmaceuticsconference.com/speaker/omonike-a-olaleye 0.8 https://pharmaceuticsconference.com/speaker/stephen-hart 0.8 https://pharmaceuticsconference.com/speaker/el-hassane-larhrib 0.8 https://pharmaceuticsconference.com/speaker/arwyn-t-jones 0.8 https://pharmaceuticsconference.com/speaker/hanieh-khalili 0.8 https://pharmaceuticsconference.com/speaker/gillian-hutcheon 0.8 https://pharmaceuticsconference.com/speaker/georgina-kate-such 0.8 https://pharmaceuticsconference.com/speaker/ernst-wagner 0.8 https://pharmaceuticsconference.com/speaker/fiorenza-rancan 0.8 https://pharmaceuticsconference.com/speaker/philippe-barthelemy 0.8 https://pharmaceuticsconference.com/speaker/giancarlo-morelli 0.8 https://pharmaceuticsconference.com/speaker/laura-cerchia 0.8 https://pharmaceuticsconference.com/speaker/ricardo-perez-tomas 0.8 https://pharmaceuticsconference.com/speaker/maria-j-vicent 0.8 https://pharmaceuticsconference.com/speaker/madhav-bhatia 0.8 https://pharmaceuticsconference.com/speaker/sulabh-patel 0.8 https://pharmaceuticsconference.com/speaker/ulo-langel 0.8 https://pharmaceuticsconference.com/speaker/kira-astakhova 0.8 https://pharmaceuticsconference.com/speaker/ana-margarida-grenha 0.8 https://pharmaceuticsconference.com/speaker/teresa-m-v-d-pinho-e-melo 0.8 https://pharmaceuticsconference.com/speaker/luis-braz 0.8 https://pharmaceuticsconference.com/speaker/elaine-f-enright 0.8 https://pharmaceuticsconference.com/speaker/jitka-pracharova 0.8 https://pharmaceuticsconference.com/speaker/csaba-heteny 0.8 https://pharmaceuticsconference.com/speaker/arik-dahan 0.8 https://pharmaceuticsconference.com/speaker/rina-rosin-arbesfeld 0.8 https://pharmaceuticsconference.com/speaker/ana-carolina-kogawa 0.8 https://pharmaceuticsconference.com/speaker/mikhail-samuilovich-goizman 0.8 https://pharmaceuticsconference.com/speaker/konstantin-ostrovskiy 0.8 https://pharmaceuticsconference.com/speaker/katherina-fernandez 0.8 https://pharmaceuticsconference.com/speaker/mehmet-ay 0.8 https://pharmaceuticsconference.com/speaker/ferah-comert-onder 0.8 https://pharmaceuticsconference.com/speaker/elod-erno-nagy 0.8 https://pharmaceuticsconference.com/speaker/sandip-gite 0.8 https://pharmaceuticsconference.com/speaker/vandana-b-patravale 0.8 https://pharmaceuticsconference.com/speaker/mino-r-caira 0.8 https://pharmaceuticsconference.com/speaker/sarmad-al-edresi 0.8 https://pharmaceuticsconference.com/speaker/john-wahlich 0.8 https://pharmaceuticsconference.com/speaker/amal-abukhares 0.8 https://pharmaceuticsconference.com/speaker/gemma-vilar 0.8 https://pharmaceuticsconference.com/speaker/anna-kluk 0.8 https://pharmaceuticsconference.com/speaker/svetlana-n-morozkina 0.8 https://pharmaceuticsconference.com/speaker/booyong-lee 0.8 https://pharmaceuticsconference.com/speaker/tugba-gungor 0.8 https://pharmaceuticsconference.com/speaker/cansel-kose-ozkan 0.8 https://pharmaceuticsconference.com/speaker/amit-mirani 0.8 https://pharmaceuticsconference.com/speaker/pratik-s-kakade 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026 2026-05-27 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/from-marker-to-mechanism-ligand-discovery-enables-functional-analysis-of-or51e1-an-ectopic-olfactory-receptor-in-prostate-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/personalized-and-precision-medicine-ppm-as-a-unique-healthcare-model-based-on-design-inspired-biotech-biopharma-driven-applications-to-secure-the-human-healthcare-and-biosafety 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/biocompatible-synthesis-of-non-crystalline-iron-oxide-nanoparticles-with-stable-colloidal-properties 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/a-nams-compatible-mechanopharmacological-model-of-drug-penetration-in-the-urinary-bladder 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/antibody-proteases-as-translational-tools-of-the-next-step-generation-to-be-applied-for-biopharmacy-related-and-precision-medical-practice 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/nebulized-mesenchymal-stem-cell-derived-exosomes-encapsulating-interferon-2b-a-synergistic-strategy-for-targeted-treatment-of-severe-viral 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/notch-targeted-tumor-microenvironment-responsive-drug-delivery-for-efficient-treatment-of-metastatic-colorectal-cancer-by-remodeling-its-signal-dynamics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/co-delivery-of-antiviral-and-anti-inflammatory-agents-via-dry-powder-inhalation-for-viral-pneumonia 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/fabrication-of-anti-egfr-grafted-lipid-nanoparticles-for-effective-delivery-of-anti-cancer-drug-a-multifaceted-approach-combating-breast-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/non-crystalline-stabilization-of-iron-oxide-nanoparticles-enables-a-versatile-platform-for-carrier-dependent-and-carrier-free-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/azobenzene-enriched-peg-plga-micelles-as-a-light-responsive-drug-delivery-platform-effect-of-light-on-biological-activity 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/electrospun-mucoadhesive-nanofiber-platform-incorporating-functionalized-gold-nanorods-for-nose-to-brain-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/self-assembled-dna-collagen-bioactive-scaffolds-for-enhanced-cellular-uptake-and-neuronal-differentiation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/ultrasound-responsive-bioactive-microbubbles-for-enhanced-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/ligand-directed-and-ph-responsive-liposomal-systems-for-advanced-pulmonary-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/easily-injectable-organic-solvent-free-self-assembled-hydrogel-platform-for-endoscope-mediated-gastrointestinal-polypectomy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/overcoming-the-peg-dilemma-via-tris-based-surface-engineering-for-acidic-microenvironment-responsive-tumor-specific-uptake-and-intracellular-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/road-to-relief-managing-varicose-vein-in-labour-and-professional-drivers 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/pharmacovigilance-in-algeria-current-status-challenges-and-future-perspectives 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/hepatotoxic-botanicals-shadows-of-pearls 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/the-impact-of-metal-decorated-polymeric-nanodots-on-proton-relaxivity 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/r-d-consultancy-at-the-medicines-discovery-catapult-de-risking-drug-discovery-for-innovators 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/design-and-characterization-of-gum-arabic-buccal-films-for-protein-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/application-of-quality-by-design-for-pulmonary-liposomes-preliminary-study-to-nano-in-microparticle 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/design-and-optimization-of-a-nanotechnological-platform-for-future-delivery-of-sarcomphalus-joazeiro-mart-extract-in-dental-bleaching 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/design-and-development-of-iontophoretic-and-transdermal-patch-of-methotrexate 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/alkaline-earth-metal-ion-modified-black-phosphorene-nanoplatforms-for-anticancer-drug-delivery-and-phototherapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/glucose-responsive-smart-polymeric-nanocarriers-for-oral-insulin-delivery-design-optimization-and-preclinical-evaluation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/improved-anti-psoriatic-activity-of-anti-inflammatory-dendrimers-using-fluid-catanionic-vesicle-based-formulations 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/development-of-des-modified-lignin-nanoparticle-and-nanodiamond-based-smart-nano-drug-delivery-platforms-for-the-treatment-of-glioblastoma 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/arteether-nanoemulsion-for-enhanced-oral-efficacy-against-plasmodium-yoelii-nigeriensis-a-bioavailability-driven-approach 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/ph-responsive-drug-release-of-5-fluorouracil-using-cuinzns-zns-as-therapeutic-drug-carriers 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/peptide-based-inhibition-of-ania-homologs-and-modulation-of-biofilm-related-gene-expression-in-pseudomonas-aeruginosa 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/strain-dependent-inhibition-of-bacterial-growth-and-biofilm-formation-by-kaolin 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/oral-delivery-of-entecavir-with-hydroxypropyl-methylcellulose-as-solid-dispersion 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/cyclodextrin-metal-organic-frameworks-as-an-advanced-platform-for-high-efficiency-drug-delivery-and-controlled-release 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/isolation-and-characterization-of-alkaloids-from-the-tertiary-alkaloid-extract-of-papaver-umbonatum-boiss-and-evaluation-of-their-antibacterial-and-antioxidant-activities 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/anthracycline-induced-chemotherapy-cardiotoxicity-and-its-impact-in-odonto-stomatological-practice 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/development-of-novel-drug-delivery-pathways-enabled-by-perillyl-alcohol-neo100-a-monoterpene-with-multifaceted-biomedical-applications 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/principles-and-standards-for-managing-healthcare-transformation-towards-personalized-preventive-predictive-participative-precision-medicine-ecosystems 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/hydrogen-sulfide-in-sepsis-from-bench-to-bedside 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/biocompatibility-and-subcutaneous-host-response-to-silk-fibroin-chitosan-composite-plugs-progress-toward-biodegradable-implant-materials 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/from-in-silico-docking-to-in-vivo-relevance-predicting-drug-binding-to-ligand-bound-human-serum-albumin 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/platelet-activating-factor-receptor-pathway-mediates-solar-radiation-induced-extracellular-vesicle-release-in-human-keratinocytes 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/high-throughput-optimization-of-cell-specific-lipid-nanoparticles-through-learning-to-rank 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/polydopamine-based-advance-drug-delivery-systems 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/evaluation-of-surface-charged-donepezil-loaded-liposomes-for-intranasal-nose-to-brain-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/infant-exposure-to-cannabinoids-via-the-mother-s-milk 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/an-integrated-therapeutic-strategy-to-enhance-cuproptosis-through-adaptive-activation-and-microenvironment-remodeling-of-prodrug-complexes 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/exploring-classical-ayurvedic-drugs-in-hypertension 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/formulation-optimization-and-in-vitro-characterization-of-chitosan-alginate-polyelectrolyte-complex-microbeads-incorporated-into-a-natural-hydrophilic-matrix-for-extended-oral-delivery-of-an-antihypertensive-drug 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/development-of-stable-liquid-formulation-of-fibrinogen 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/pharmaceutical-contaminants-in-the-environment-risk-assessment-challenges-and-remediation-approaches 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/ai-guided-chrono-nanoformulation-a-new-paradigm-in-circadian-targeted-drug-delivery-systems 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/from-design-to-activity-linker-flexibility-in-3-spiro-2-oxindoline-vegfr-2-inhibitors 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/characterization-antibacterial-and-cytotoxic-activities-of-silver-nanoparticles-using-the-whole-biofilm-layer-as-a-macromolecule-in-biosynthesis 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/novel-thiadiazine-thiones-and-their-biological-screening-as-prodrug-candidates 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/integrating-sudanese-medicinal-plants-into-modern-pharmaceutics-a-sustainable-approach-to-drug-discovery-and-formulation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/fabrication-and-evaluation-of-multidrug-fixed-dose-combination-tablets-for-paediatric-tuberculosis-using-fused-deposition-modelling-fdm-3d-printing-technology 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/role-of-artificial-intelligence-in-drug-discovery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/structure-based-design-and-smart-formulation-of-stimuli-responsive-nanocarriers-bridging-computational-docking-with-advanced-drug-delivery-for-targeted-therapeutics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/diabetes-risk-stratification-using-self-reported-health-indicators-a-machine-learning-and-explainability-approach 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/cognitivevoice-novel-machine-learning-model-leveraging-acoustic-features-to-predict-future-cognitive-decline-in-parkinson-s-disease 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/overcoming-astrocyte-regulated-blood-brain-barrier-recent-advances-in-novel-drug-delivery-systems-for-cns-disorders 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/stimuli-responsive-smart-drug-delivery-systems-emerging-strategies-in-precision-medicine 0.8 https://pharmaceuticsconference.com/program/scientific-program/2026/microplastics-in-the-human-testis-new-evidence-mechanism-and-pharmacological-implication-in-the-male-reproductive-health 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/ectopically-expressed-olfactory-receptors-as-an-untapped-family-of-drug-targets-and-discovery-of-agonists-and-antagonists-of-or51e1-an-understudied-g-protein-coupled-receptor 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/innovative-development-and-delivery-of-biologics-for-chronic-obstructive-pulmonary-disease 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/personalized-and-precision-medicine-ppm-as-a-unique-healthcare-model-through-de-sign-inspired-biotech-biopharma-driven-applications-and-upgraded-business-mar-keting-to-secure-the-human-healthcare-and-biosafety 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/macitentan-tadalafil-combination-an-additional-value-in-pharmacotherapy-of-pulmonary-arterial-hypertension 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/identification-of-sulfonamide-based-aromatase-inhibitors-in-the-breast-cancer-research 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/pharmacology-of-chlorphenamine-and-pseudoephedrine-use-in-the-common-cold 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/antibody-proteases-as-translational-tools-of-the-next-step-generation-to-be-applied-for-biopharmacy-related-and-precision-medical-practice 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/is-paracetamol-acetaminophen-still-a-first-line-option-for-pain-and-fever-in-paediatrics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/innovations-in-rivastigmine-delivery-nanostructured-lipid-carriers-encapsulated-in-microneedles-for-enhanced-transdermal-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/assessment-of-inulin-content-in-arctium-lappa-l-root-extract-potential-for-nutritional-and-medicinal-applications 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/evaluating-aronia-melanocarpa-varieties-for-pharmaceutical-applications-based-on-polyphenolic-content-and-antioxidant-activity 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/therapeutic-efficacy-of-nanostructured-lipid-carriers-co-loaded-with-simvastatin-and-adenosine-nlc-sa-in-a-human-epidermal-model-of-diabetic-chronic-wound 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/advances-in-hydrophilic-drug-delivery-encapsulation-of-biotin-in-alginate-microparticles 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/formulation-and-characterization-of-buccal-films-based-on-sodium-alginate-and-chitosan-for-using-in-parkinsons-disease 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/the-promise-of-nanotechnology-in-personalized-precision-medicine-drug-discovery-development-being-partnered-with-nanotechnologies-via-the-revolution-at-the-nanoscale 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/gastroplus-and-admet-predictor-driven-predictive-model-for-pharmacokinetic-parameters-of-endol-immediate-release-capsule 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/enhancing-delivery-of-biopharmaceutics-classification-system-class-ii-drugs-through-a-novel-carrageenan-alginate-oleogel-matrix-a-case-study-on-praziquantel-for-improved-therapeutic-efficacy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/what-caffein-brings-to-paracetamol-acetaminophen-in-pain-management 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/enabling-active-pharmaceutical-ingredient-industry-in-saudi-arabia 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/intelligent-delivery-of-5-fluorouracil-using-smart-polymers 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/astrotactin-2-as-novel-analgesic-target-candidate-for-cancer-pain-and-opioid-sparing-an-exploratory-genetic-polymorphism-analysis 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/evaluating-maleic-anhydride-derivatives-as-linkers-for-ph-sensitive-drug-release 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/evaluating-maleic-anhydride-derivatives-as-linkers-for-ph-sensitive-drug-release 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/evaluating-maleic-anhydride-derivatives-as-linkers-for-ph-sensitive-drug-release 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/liposomal-formulation-and-quantitative-hplc-analysis-of-random-peptide-mixtures-for-antibacterial-drug-development 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/liposomal-formulation-and-quantitative-hplc-analysis-of-random-peptide-mixtures-for-antibacterial-drug-development 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/the-physicochemical-biopharmaceutical-and-in-vitro-efficacy-properties-of-diclofenac-loaded-liposomes 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/analytical-strategies-for-solid-state-forms-in-drug-development 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/understanding-drug-transport-in-plasma-the-role-of-protein-binding 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/design-and-evaluation-of-exo-itc-a-bilayer-fibrous-system-for-controlled-exosome-delivery-in-dermatological-applications 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/mathematical-modeling-the-disc-diffusion-test-antibacterial-activity-of-copper-doped-sno2 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/emerging-formulation-and-delivery-applications-of-vitamin-e-tpgs 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/medical-liver-biopsy-toward-a-personalized-approach 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/psychedelic-drugs-safety-problems-in-pregnancy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/morphological-versatility-of-hybrid-systems-mimicking-the-self-assembly-of-natural-structures 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/drug-development-importance-trends-and-digital-transformation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/biodegradable-ribbon-for-roll-porous-scaffold-3d-bioprinting-technology 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/cu-n-pd-ni-nanocomposites-from-wastes-printed-circuit-boards-pcbs-to-remove-endocring-disruptors 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/nanoparticle-mediated-drug-delivery-system-in-cerebrovascular-disorders 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/mechanistic-insights-into-phlorizin-s-multi-target-potential-in-alzheimer-s-disease-a-network-pharmacological-and-in-vivo-study 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/design-and-computational-analysis-of-a-peptide-analogue-with-a-wxxw-motif-a-membrane-active-and-reversible-drug-binding-peptide-to-overcome-cancer-drug-resistance 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/lysozyme-enzybiotic-as-promising-weapon-against-antimicrobial-resistance 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/acetaminophen-over-the-counter-drug-applications-and-safety-concerns 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/formulation-and-evaluation-of-the-pilosomes-as-drug-delivery-system-pdds 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/therapeutic-drug-development-using-biopolymer-degrading-enzymes 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/ayurvedic-bhasmas-as-a-nano-medicines-for-the-human-kind 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/c-elegans-as-a-platform-for-studying-neurodegenerative-diseases-identification-of-antioxidants-as-therapeutic-agents 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/isolation-and-evaluation-of-antioxidant-and-cytotoxic-activity-of-2-4-dihydroxy-3-5-dimethyl-6-methoxychalcone-from-the-ethyl-acetate-extract-of-the-leaves-of-syzygium-balsameum-wight-wall-ex-walp 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/biotechnological-methods-for-optimizing-secondary-metabolite-production-in-plants-for-pharmaceuticals 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/impact-of-histone-deacetylase-isoform-on-the-effectiveness-of-immune-checkpoint-therapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/green-chemistry-honey-based-synthesis-of-silver-nanoparticles-and-the-evaluation-of-their-antibacterial-activities 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/pharmacometrics-evolution-current-applications-and-future-horizons-in-drug-development-and-personalized-medicine 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/aloe-leaf-juice-as-a-basis-for-antiseptic-enhanced-wound-healing-agents-in-wartime 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/impact-of-sugars-on-electrospray-dried-peptide-protein-powder-formulations 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/quality-assurance-framework-for-implementing-therapeutic-drug-monitoring-in-preterm-infants-enhancing-safety-and-precision-in-neonatal-care 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/eco-friendly-hydrotropic-technology-in-pharmaceutical-analysis-precluding-the-use-of-hazardous-organic-solvents 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/diabetes-risk-stratification-using-self-reported-health-indicators-a-machine-learning-and-explainability 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/the-effect-of-finasteride-on-parity-rates-in-drosophila-melanogaster 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/eliminating-implant-failure-in-humans-with-nanomaterials-30-000-cases-and-counting 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/managing-healthcare-transformation-towards-personalized-preventive-predictive-participative-precision-medicine-ecosystems 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/search-for-novel-biomarkers-and-therapeutic-targets-for-inflammatory-disease 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/abuse-deterrent-dosage-form-technique-utilizing-a-fusion-of-innovative-pharmaceuticals-and-ion-exchange-resin 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/in-silico-analysis-for-the-screening-and-selection-of-repurposed-drugs-and-mitochondrial-targets-for-drug-development-and-delivery-for-oscc-therapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/fast-nanotechnology-a-novel-platform-for-drug-development-and-beyond 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/development-of-novel-drug-delivery-pathways-enabled-by-perillyl-alcohol-neo100-a-monoterpene-with-multifaceted-biomedical-applications 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/precision-oncology-and-personalised-medicine-innovative-technology-for-the-treatment-of-colorectal-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/drug-delivery-strategies-for-the-management-of-microbial-infections-and-wound-healing 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/medication-errors-detection-impact-and-risk-reduction-through-pharmacovigilance 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/from-self-assembly-to-healing-engineering-ultra-small-peptides-into-supramolecular-hydrogels-for-controlled-drug-release 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/study-of-serum-adiponectin-and-hscrp-in-diabetic-patients 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/cannabinoid-acids-for-the-treatment-of-multiple-sclerosis 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/chemo-enzymatic-synthesis-of-bridged-nucleosides 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/epigenetics-in-drug-development-unlocking-novel-therapeutic-strategies-for-precision-medicine 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/impact-and-challenges-supply-chain-realibity-in-pharmaceutical-process-development 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/development-pharmaceutical-analysis-and-invitro-evaluation-of-modified-herbal-fumigation-formulations 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/novel-nucleobase-2-oxindole-heterocyclic-hybrids-as-selective-cell-cycle-regulators-with-potential-anticancer-activities 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/pharmacopollution-trends-over-time 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/personalized-medicine-tailoring-drug-delivery-systems-for-targeted-therapeutic-efficacy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/comprehensive-analytical-and-bioanalytical-method-validation-for-the-quantification-of-linagliptin-and-empagliflozin-in-fixed-dose-combinations 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/cholesterol-lowering-and-regulation-of-inflammation-by-pcsk9 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/analytical-methods-based-on-liquid-chromatography-tandem-mass-spectrometry-for-the-detection-of-genotoxic-nitrosamine-impurities 0.8 https://pharmaceuticsconference.com/program/scientific-program/2025/the-critical-role-of-lung-safety-in-regulatory-approval-of-systemic-inhalation-delivery-products 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/personalized-and-precision-medicine-ppm-as-a-unique-healthcare-model-to-be-set-up-via-biodesign-bio-and-chemical-engineering-translational-applications-and-upgraded-business-modeling-to-secure-the-human-healthcare-and-biosafety 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/pharmacokinetic-properties-of-tnx-102-sl-a-sublingual-formulation-of-cyclobenzaprine-hydrochloride 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/mannitol-as-eutectic-forming-agent-for-improved-sublingual-delivery-of-cyclobenzaprine-hcl 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/clinical-decision-making-in-advanced-and-metastatic-breast-cancer-cases-between-parp-inhibitors-and-cdk4-6-inhibitors 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/gastrointestinal-performance-simulation-system-for-the-analysis-of-eltrombopag-formulations 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/microemulsion-based-in-situ-gel-of-erythromycin-for-ocular-ailments 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/preparation-and-characterization-of-inhaled-luteolin-nano-liposomes-for-the-potential-management-of-pulmonary-arterial-hypertension 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/supercritical-microfluidic-system-for-production-of-nanoparticles-and-liposomes-for-pharmaceutical-formulation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/the-promise-of-nanotechnology-in-personalized-precision-medicine-drug-discovery-development-being-partnered-with-nanotechnologies-via-the-revolution-at-the-nanoscale 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/development-and-evaluation-of-prolonged-release-dutasteride-transdermal-delivery-system 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/potential-bruton-tyrosine-kinase-btk-inhibitors-determined-by-virtual-screening-molecular-docking-and-molecular-dynamics-simulation-studies 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/in-silico-synthesis-and-in-vitro-studies-of-novel-foxm1-inhibitors-for-targeted-triple-negative-breast-cancer-therapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/design-and-assessment-of-transdermal-delivery-system-containing-levodopa-loaded-nanoparticles 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/emerging-formulation-and-delivery-applications-of-vitamin-e-tpgs 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/drug-design-for-the-development-of-long-acting-injectables 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/clinical-pharmacology-of-aprocitentan-an-endothelin-receptor-antagonist-the-most-recent-quality-progress-in-treatment-of-resistant-hypertension 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/crystallographic-in-pharmaceutical-filed-new-frontiers 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/an-updated-review-on-the-central-mechanism-of-action-of-paracetamol-acetaminophen-experimental-evidence-and-potential-clinical-impact 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/innovations-in-dna-and-rna-vaccine-technology-their-impact-on-treatment-efficacy-and-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/hybrid-compounds-a-useful-strategy-to-overcome-limited-pharmaceutical-profile 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/an-enteric-capsule-for-oral-drug-delivery-made-from-natural-materials 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/development-of-a-sensitive-method-for-the-determination-of-enrofloxacin-in-falsified-veterinary-products 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/the-importance-of-invitro-discriminatory-tests-in-the-development-of-a-sublingual-dosage-form-of-tnx102-sl-cyclobenzaprine-hcl-tablets 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/pharmaceutical-continuous-manufacturing-the-interaction-between-different-units-and-tablet-properties 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/lipid-media-with-supercritical-co2-for-promoted-formation-of-itraconazole-cocrystals 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/gastrointestinal-performance-simulation-system-for-the-analysis-of-eltrombopag-formulations 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/an-updated-review-on-the-central-mechanism-of-action-of-paracetamol-experimental-evidence-and-potential-clinical-impact 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/paeoniflorin-effectively-inhibit-melanoma-growth-through-induce-senescence-and-er-stress-converging-on-the-calpain1-erk5-p21-axis 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/polymeric-based-formulation-for-intelligent-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/why-we-need-to-advance-from-data-focus-to-knowledge-focus-for-managing-healthcare-transformation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/unveiling-the-binding-interactions-of-selected-antimalarial-drugs-with-major-plasma-transporter 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/photodegradation-of-two-pharmaceutical-namely-levofloxacin-and-atorvastatin-via-chitosan-ag-tio2-3d-printed-scaffold 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/liver-biopsy-handling-of-metabolic-associated-fatty-liver-disease-mafld-the-childrens-hospital-of-eastern-ontario-grossing-protocol 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/perillyl-alcohol-neo100-a-monoterpene-with-versatile-applications-for-cancer-therapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/preparation-and-characterization-of-fibers-crafted-from-pcl-pvp-chagg-coupled-with-investigating-their-suitability-as-wound-dressings 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/hydrogen-sulfide-and-substance-p-novel-mediators-and-therapeutic-targets-for-acute-pancreatitis 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/integrating-qbd-for-the-solubility-amelioration-of-ivacaftor-loaded-solid-lipid-nanoparticles-in-vitro-in-vivo 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/computational-modelling-for-enhanced-drug-delivery-in-drug-coated-balloon-treatment 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/impact-of-implementation-of-antimicrobial-stewardship-amsp-and-infection-prevention-and-measures-ipc-on-mdro-profiles-in-a-tertiary-care-hospital-of-india 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/unveiling-green-chemistry-exploring-sustainable-practices 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/comparison-of-in-vitro-drug-dissolution-profiles-current-state-and-examination-of-etravirine-tablets 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/design-and-development-of-controlled-release-systems-versatility-in-drug-formulation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/structure-elucidation-of-drug-targets-through-homology-modeling-in-the-ai-era 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/mesenchymal-stromal-cells-as-therapeutic-tools-in-immune-disorders-promising-evidence-from-in-vitro-results 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/novel-2-5-disubstituted-oxadiazole-scaffolds-act-as-potential-antitumour-and-antibacterial-agents 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/role-of-natural-polymers-in-drug-delivery-system 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/synthetic-antimicrobial-peptides-as-potent-therapeutic-agents 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/uplc-method-development-and-validation-for-the-estimation-of-sulbactam-and-durlobactum-in-pharmaceutical-dosage-form 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/pcsk9-roles-beyond-cholesterol-lowering 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/human-papillomavirus-vaccines-and-impact-on-decreasing-of-infection-the-population 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/a-novel-method-of-active-medication-delivery-via-microneedles-using-a-belousov-zhabotinsky-oscillating-hydrogel 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/health-risks-associated-with-exposure-to-organic-sunscreens-during-pregnancy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/breakthrough-fast-precise-and-inexpensive-3d-bioprinting-of-organoids-and-blood-vessels 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/ai-guided-spectroscopy-and-recombinant-dna-technologies-to-discover-the-new-lantibiotics-and-phytobiotics-against-multi-drug-resistant-infections 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/telomere-length-inflammatory-markers-and-oxidative-stress-in-pre-eclamptic-women 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/novel-chromogenic-method-as-a-sensitive-technique-in-estimating-analytes 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/preparation-and-evaluation-of-herbosome-of-herbal-plant-of-lawsonia-inermis-l-for-topical-application 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/targeted-downregulation-of-vegf-a-to-inhibit-angiogenesis-in-psoriasis-using-crispr-cas9-complexed-lipopolymeric-nanoplexes 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/the-impact-of-climate-change-on-medicinal-plant-availability-and-efficacy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/natural-plant-based-extract-mediated-cell-death-induction-potential-in-human-cancer-cells-in-vitro-and-in-silico-strategies-for-drug-development 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/pharmaceuticals-in-the-environment-boon-or-bane 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/global-drug-development-trends-challenges-and-opportunities 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/tetrahydro-2h-1-3-5-thiadiazine-2-thione-thtt-a-versatile-carrier-system-for-targeting-cell-cycle-checkpoint-pathways-with-potential-anticancer-activities 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/surface-chemistry-and-particle-interactions-in-materials-and-their-impact-on-powder-performance 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/from-medicationalization-to-pharmaco-pollution-raising-awareness-on-the-hidden-costs-of-overprescribing 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/understanding-abc-transporters-to-navigate-human-diseases 0.8 https://pharmaceuticsconference.com/program/scientific-program/2024/structural-scheme-of-an-electro-magneto-elastic-actuator-for-nanomedical-research 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/new-approach-to-hyponatremia-yields-high-prevalence-and-identification-of-natriuretic-protein-that-causes-renal-salt-wasting-rsw-and-new-syndrome-of-rsw-in-alzheimer-s-disease 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/synergism-in-the-permeability-of-the-blood-brain-barrier-between-heavy-metals-and-electromagnetic-fields 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/manufacturing-outlook-on-cell-and-gene-and-aseptic-processing-according-the-eu-gmp-annex-1 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/multi-detection-of-pharmaceutical-contamination-in-environment 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/the-role-of-non-antibiotic-drugs-on-the-development-of-antibiotic-resistance 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/digital-health-education-in-clinical-pharmacy-and-implementation-in-practice 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/novel-glutatione-based-formulations-for-targeting-the-nlrp3-inflammasome-in-the-treatment-of-cardiovascular-diseases 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/pharmacovigilance-important-current-trends-challenges-and-opportunities 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/maternal-fetal-and-neonatal-outcomes-for-women-exposure-during-pregnancy-to-covid-19-vaccines 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/synergy-of-antioxidant-and-drug-delivery-abilities-of-glycyrrhizin 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/intellection-of-molecular-drug-delivery-models-an-ayurvedic-perspective 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/biotechnological-exploration-of-phyto-drugs-against-mdr-bacteria-targeting-dna-topoisomerase-i-and-rna-polymerase 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/chemo-enzymatic-approach-to-synthesis-of-modified-nucleosides 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/investigating-the-effect-of-liposomal-membrane-rigidity-on-the-permeability-of-doxorubicin 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/design-synthesis-of-some-novel-chromen-derivatives-and-evaluation-of-their-effectiveness-as-the-inhibitors-of-sars-cov-2-virus-3cl-protease-enzyme 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/emerging-formulation-and-delivery-applications-of-vitamin-e-tpgs 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/further-studies-on-a-new-family-of-antibiotics-produced-by-cryptic-biosynthesis-in-extremophilic-fungi 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/the-role-of-plants-in-modern-drug-discovery-and-screening 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/prescription-of-potentially-inappropriate-medicines-and-comparison-with-lists-of-essential-medicines-for-treatment-of-chronic-disorders-in-older-patients 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/preparation-of-uniform-hyaluronic-acid-nanoparticles-for-biomedical-applications 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/hdac-inhibitors-with-non-hydroxamate-warhead 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/the-new-benzamide-derivatives-as-potential-dementia-drugs-synthesis-biological-activity-and-molecular-docking-study 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/chameleon-nanocarriers-for-dynamic-delivery-of-rna-medicines 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/human-nanomedicine-emphasizing-results-of-nanomaterials-in-humans 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/mucoadhesive-electrospun-fibers-in-oral-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/qualitative-and-quantitative-measures-of-drugs-placenta-permeability-a-chromatographic-and-computational-approach 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/new-approaches-to-inhibit-mirnas-in-an-atherosclerosis-pre-clinical-model 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/pharmacological-properties-of-bexagliflozin-a-novel-sodium-glucose-cotransporter-2-sglt2-inhibitor 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/photodegradation-of-tetracycline-using-zno-fe2o3-nanocomposite 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/fentanyl-mental-health-and-society 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/apoptosis-in-colon-cancer-cell-line-through-down-regulation-of-akt-pathway 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/mechanisms-of-chemotherapy-drug-induced-microvesicle-particles-release 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/interdependent-antioxidant-therapy-in-covid-19-and-other-critical-diseases 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/oral-mixed-micellar-system-for-peptide-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/natural-molecule-encapsulated-liposome-based-formulations-for-dermal-and-transdermal-applications-for-cancer-therapeutics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/formulation-characterization-and-evaluation-micellar-loaded-complex-of-cuminum-cyminum-to-treat-causing-disease-of-covid-19-respiratory-infection 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/artificial-intelligence-based-strategy-for-personalized-medicine 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/thiadiazine-2-thione-derivatives-as-new-carrier-systems-for-isothiocyanates-and-dithiocarbamic-acid-with-potential-anticancer-activities 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/pcsk9-s-role-in-immunomodulation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/sustainable-management-of-pharmaceutical-waste-smart-labeling-for-the-reuse-of-unexpired-medications 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/understanding-hepatitis-b-virus-inhibitor-clevudine-transport-in-human-blood-circulation-an-in-vitro-albumin-binding-study 0.8 https://pharmaceuticsconference.com/program/scientific-program/2023/mesenchymal-stromal-cells-and-immunoregulatory-properties-concerns-and-issues-utilizing-novel-stem-cell-therapy-as-potential-therapeutic-strategy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/development-and-evaluation-of-structured-strategic-approach-for-successful-accomplishment-of-risk-based-monitoring-model-from-clinical-trial-inception-to-completion-at-clinical-trial-organization 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/latest-trends-in-bio-degradation-of-xenobiotics-for-cleaning-up-the-environment 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/acetylcholinesterase-and-atpases-targets-of-biologically-active-compounds 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/understanding-the-issues-with-recruitment-in-pediatric-clinical-trials-in-india-as-cited-by-key-stake-holders-and-to-draw-down-the-strategies-for-better-recruitment 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/an-insight-to-anti-acne-potentials-in-vitro-ex-vivo-and-in-vivo-models 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/advanced-cancer-diagnosis-and-therapy-using-carbon-nanodots-tetrapyrrolic-macrocycles-conjugates 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/api-characterization-why-dissolution-testing-can-help-you-learn-more-about-active-ingredient 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/chlorine-dioxide-as-root-canal-irrigation-solution-in-endodontic-treatment 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/prodrugs-of-non-steroidal-anti-inflammatory-drugs-nsaids-and-amino-acid-esters-as-novel-non-cyclooxygenase-inhibitors-for-colorectal-cancer-chemoprevention 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/continuous-glucose-monitors-impact-on-glycemic-control-among-american-indian-and-alaskan-natives-single-center-pre-post-comparison 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/formulation-and-evaluation-of-escitalopram-loaded-bio-nanosuspension-for-brain-specificity 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/medicine-waste-pollution-a-brazilian-view-about-pharmacopollution-and-public-health 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/understanding-abc-transporters-to-navigate-human-diseases 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/ape-1-redox-activity-inhibition-impacts-dopaminergic-system-in-inflammatory-pain-condition 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/critical-issues-related-to-plant-and-pharmaceutical-biotechnologies-to-achieve-nations-development-and-welfare 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/development-and-in-vitro-evaluation-of-k-carrageenan-bead-for-sustained-delivery-of-repaglinide 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/method-for-tailoring-diabetes-simulator-for-optimal-in-silico-trial-in-target-populations 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/drug-delivery-to-the-brain-using-engineered-protein-capsules-enpcs 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/arsenate-target-specific-cell-death-mechanism-in-normal-and-tumoral-breast-cancer-cell-lines 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/cardiac-myosin-inhibitors-new-pharmacological-approach-for-obstructive-hypertrophic-cardiomyopathy-treatment 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/hydrogen-sulfide-a-stinky-gas-and-novel-therapeutic-target-for-inflammatory-disease 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/vaccines-against-rotavirus-data-based-on-a-study-for-safety-and-efficacy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/self-microemulsifying-systems-based-topical-lipstick-of-antifungal-agent 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/immune-checkpoint-inhibitors-icis-and-immune-related-adverse-drug-reactions-focus-on-their-neurotoxicity 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/catecholase-activity-electrochemistry-and-magnetic-behavior-of-a-azido-bridged-dinuclear-copper-ii-complex-of-a-phenol-based-end-off-compartmental-ligand 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/formulation-and-optimization-of-self-micro-emulsifying-drug-delivery-system-smedds-of-clopidogrel-bisulfate-by-using-d-optimal-mixture-design 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/novel-connective-tissue-growth-factor-ctgf-loaded-alginate-and-alginate-sulfate-polycaprolactone-nanoparticles-with-promising-wound-healing-activity 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/monograph-on-butea-monosperma-palas-an-important-plant-for-lac-cultivation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/a-novel-drug-delivery-system-fast-dissolving-film-containing-niosomes 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/future-needs-for-inhaled-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/aryl-amine-content-determination-in-different-indian-brands-of-hair-dyes-by-analytical-techniques 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/formulation-and-evaluation-of-tablet-containing-different-variety-of-native-starches 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/synthesis-characterization-biological-and-molecular-docking-studies-of-z-n-substituted-4-pyridin-2-yl-6-1h-pyrrolo-2-3-b-pyridin-4-yl-pyrimidin-2-amine 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/the-intrinsic-antibiotic-resistance-of-environmental-bacterial-species-a-clue-to-understand-the-emerging-of-multi-drug-resistant-strains 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/characteristic-features-of-essential-oil-composition-in-selected-genus-of-ocimum-sanctum 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/intranasal-drug-delivery-perillyl-alcohol-neo100-for-glioblastoma-leads-the-way 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/development-and-characterization-of-salbutamol-sulfate-dry-powder-inhaler-formulations-for-asthma-management 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/a-new-approach-based-on-glycyrrhizic-acid-for-allergen-delivery-in-allergen-specific-therapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/an-immunoactive-polymer-mediates-nucleic-acids-delivery-for-cancer-immunotherapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/mucoadhesive-systems-for-the-fast-delivery-of-drugs 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/formulation-development-and-evaluation-of-chronotherapeutic-drug-delivery-system-for-the-treatment-of-nocturnal-asthma 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/self-nanoemulsifying-drug-delivery-system-snedds-of-apremilast-in-vitro-evaluation-and-pharmacokinetic-studies 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/antibiotic-and-phytoconstituent-combination-loaded-gastric-floating-microsponge-for-the-effective-eradication-of-helicobacter-pylori-infection-formulation-physicochemical-and-microbiological-assessments 0.8 https://pharmaceuticsconference.com/program/scientific-program/2022/the-effect-of-commercially-available-dpis-on-respiratory-drug-aerosolization 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/in-vitro-anticancer-screening-of-crude-plant-polar-extracts 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/crystallization-process-of-api-active-pharmaceutical-ingredients-for-dosage-form-design 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/in-vitro-pharmacokinetics-of-topically-applied-compounds-from-various-formulations-across-porcine-skin 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/experimental-design-of-ciprofloxacin-hcl-loaded-nanoparticle-formulation-for-an-enhanced-antimicrobial-activity 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/mechanistic-insights-into-side-effects-of-troglitazone-and-rosiglitazone-using-a-novel-inverse-molecular-docking-approach 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/boosting-oral-bioavailability-though-solid-lipid-nanoparticle-approach 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/design-and-formulation-of-doxycycline-polymeric-nanoparticles-and-testing-antitumor-and-antiangiogenic-activity-in-mouse-colon-cancer-model 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/amelioration-effect-of-black-seed-oil-against-high-fat-diet-induced-obesity-in-rats-through-nrf2-ho-1-pathway 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/application-of-camellia-sinensis-l-kuntze-in-traditional-medicine-and-virus-control 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/strategy-in-crystallization-process-to-ensure-solid-state-stability-of-drug-substance 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/drying-techniques-to-stabilize-nanotechnology 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/modification-of-peptides-to-increase-their-cellular-uptake 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/synthesis-and-characterization-of-biosynthetic-cellulose-based-hydrogels-with-the-potential-wound-dressing-applications-to-tackle-chronic-wounds 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/snake-and-scorpion-venom-as-a-source-for-drugs-to-treat-cancer-and-central-nervous-system-diseases 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/ophthalmic-in-situ-gels-with-balsam-poplar-buds-extract-formulation-rheological-characterisation-and-quality-evaluation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2021/affinity-effects-on-the-release-of-genetic-material-from-polyether-urethane-particles 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/improving-bioprocesses-by-using-adaptation-strategies-of-rhodococcus 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/towards-a-better-comprehension-of-present-and-future-cyberbiosecurity-vulnerabilities-fostered-by-an-interdisciplinary-security-approach 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/molecular-marker-characterization-and-petal-valorization-of-saffron-crocus-sativus-l 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/bioinformatic-approaches-on-differential-gene-expression-in-scrub-typhus-compared-to-some-other-acute-febrile-infections 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/biotechnological-approach-to-valorize-emissions-biological-conversion-of-styrene-to-polyhydroxyalkanoates-using-two-phase-partitioning-bioreactors 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/implementation-of-conductive-materials-reduced-graphene-oxide-adorned-with-fe3o4-nanoparticles-for-biogas-upgrading 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/assessment-an-umbilical-cells-induced-neuroplasticity-in-patients-with-schizophrenia-using-functional-mri 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/an-overview-of-rsv-antiviral-medicinal-plants-that-may-be-key-to-coronavirus 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/coumarin-dihydropyrimidinone-hybrids-design-virtual-screening-synthesis-and-cytotoxic-activity-against-breast-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/the-molecular-mechanism-underlining-the-preventive-effect-of-vitamin-d-against-hepatic-and-renal-acute-toxicity-through-the-nrf2-bach1-ho-1-pathway 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/bioengineering-single-cell-oil-production-by-oleaginous-rhodococcus-spp-to-enlarge-their-application-spectrum 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/nanostructured-formulations-in-skin-cancer-challenges-and-perspectives 0.8 https://pharmaceuticsconference.com/program/scientific-program/2020/obtaining-blue-fluorescent-protein-trough-a-novel-technique 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/docetaxel-liposomes-prepared-by-the-dual-centrifugation-method-effect-of-propylene-glycol-and-lipid-charge-on-liposomal-characteristics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/delivering-type-i-interferon-to-dendritic-cells-empowers-tumor-eradication-and-immune-combination-treatments 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/lipid-and-carbohydrate-based-delivery-vesicles-for-gene-therapeutics-approaching-difficult-diseases 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/in-vitro-modeling-of-the-blood-brain-barrier-to-assess-cns-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/prototyping-and-evaluating-a-novel-humanoid-chewing-robot-for-drug-delivery-using-a-medicated-chewing-gum 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/multifunctionalized-and-targeted-biocatalytic-nanoreactor-for-combinatory-treatment-of-er-breast-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/new-approach-to-study-difference-in-nsaids-enantiomer-activity-including-chiral-inversion 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/in-situ-delivery-and-production-system-of-anti-cancer-molecules-with-gene-engineered-bifidobacterium 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/influence-of-mucoadhesivity-on-the-bioavailability-of-nanoparticulate-drug-delivery-systems 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/systemic-liver-targeting-delivery-of-a-novel-dna-rna-heteroduplex-oligonucleotide-via-an-enteral-route 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/physicochemical-and-biophysical-study-of-mechanisms-the-drugs-bioavailability-enhancement-with-new-multifunctional-delivery-systems 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/designing-adme-formulations-with-matching-exposures-to-amorphous-solid-dosage-forms 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/wound-healing-mats-made-of-layer-by-layer-coated-nanoparticles-and-electrospun-nanofibers 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/in-vitro-model-of-diclofenac-sodium-gel-delivery-through-pig-skin 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/influence-of-formulation-and-freeze-drying-process-variations-on-protein-stability 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/valproic-acid-encapsulated-biodegradable-microneedles-for-treatment-of-androgenetic-alopecia 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/therapeutic-effects-of-trehalose-liposomes-against-tumors-along-with-apoptosis 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/novel-developments-in-lipid-based-multifunctional-combination-nanopreparations-for-multidrug-resistant-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/taking-your-active-from-the-lab-to-scale-up-formulation-development-of-a-topical-delivery-systems 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/government-and-industry-response-to-the-us-opioid-epidemic 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/the-use-of-self-immolative-polymers-to-control-cellular-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/nano-versus-micro-particles-for-s-nitrosoglutathione-formulation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/pseudomonas-aeruginosa-type-3-secretion-system-mediated-antigen-delivery-for-cancer-immunotherapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/engineering-novel-selectivity-into-metalloantibodies-germline-encoded-precursor-to-the-murine-anti-s1p-metalloantibody-in-e-coli-and-baculovirus-insect-cell-system 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/discovery-of-novel-bacterial-genes-encoding-the-enzymes-acting-on-modified-uracil-uridine-derivatives-and-their-use-for-gene-therapy-in-cancer-treatment 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/drug-delivery-to-the-skin-nanostructures-for-the-treatment-of-precancerous-actinic-keratosis 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/liposomes-as-valuable-drug-delivery-systems-for-sirna-and-hsp90-inhibitors-to-target-triple-negative-breast-tumors 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/a-rna-producing-dna-hydrogel-as-a-platform-for-a-high-performance-rna-interference-system 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/metal-organic-framework-nanoparticles-preparation-of-sildenafil-a-new-window-in-the-treatment-of-pulmonary-arterial-hypertension 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/release-and-activity-of-the-broad-spectrum-antibiotic-rifampicin-from-biodegradable-polymer-plga 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/role-of-the-optimal-dynamic-state-and-stabilized-catalytic-complex-for-rational-design-of-pharmaceutical-enzymes-engineering-of-streptokinase-with-enhanced-fibrin-dependent-activity 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/pharmacovigilance-aims-challenges-and-perspectives 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/original-synthesis-of-natural-acetogenins-fattyacids-and-lembehynes-as-a-potential-drugs-for-treatment-of-cancer-and-neurodegenerative-diseases 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/the-nuclear-membrane-as-a-barrier-to-the-action-of-anthracycline-chemotherapeutics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/global-legal-tools-for-pharmacovigilance-and-risk-control 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/self-propelled-objects-with-high-autonomy-for-transportation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/nanoparticle-delivery-of-natural-products-for-the-treatment-of-lung-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/synthesis-and-physicochemical-analysis-of-multi-component-phases-in-drug-development 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/preclinical-validation-of-a-cell-penetrating-and-interfering-peptide 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/facile-preparation-and-characterization-of-robust-metal-free-nitroxide-based-magnetic-mixed-micelles-as-mri-visible-drug-delivery-carrier 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/hiv-1-integrase-tetramers-are-the-antiviral-target-of-pyridine-based-allosteric-integrase-inhibitors 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/study-of-the-capability-of-chitosan-glutathione-nanoparticles-to-modulate-redox-state-in-human-chondrocytes 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/the-biomedical-application-of-biogenic-silver-nanoparticles-produced-from-cotyledon-orbiculata 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/nano-amorphous-abiraterone-acetate-formulation-with-improved-bioavailability-and-eliminated-food-effect 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/dissolution-study-of-drug-release-from-biopolymer-matrix-tablets 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/taa-induced-liver-damage-in-klf10-knockout-mice 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/neuropeptide-y-based-recombinant-peptides-improve-bone-loss-in-mice-by-regulating-hematopoietic-stem-progenitor-cell-mobilization 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/antitumor-effects-of-retargeted-aav2-virus-on-ovarian-cancer-in-vivo 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/niosomal-encapsulation-of-curcumin-characterization-and-its-potential-as-a-therapeutic-intervention-in-asthma 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/calotropis-gigantea-extract-induces-apoptosis-through-extrinsic-intrinsic-pathways-and-reactive-oxygen-species-generation-in-a549-and-nci-h1299-non-small-cell-lung-cancer-cells 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/kinetics-of-pentoxifylline-release-from-hydrophilic-lipophilic-and-dual-matrix-tablets 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/development-of-rotigotine-nanoparticles-and-its-effect-on-haloperidol-induced-parkinsonian-symptoms-in-rats 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/synthesis-evaluation-and-computational-simulation-of-novel-coumarin-derivatives-as-potential-acetylcholinesterase-inhibitors 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/characterization-and-validation-of-tumor-cell-selective-penetrating-peptides 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/freshwater-sapropel-extract-for-use-in-medicine-and-pharmaceutics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/fabrication-and-characterization-of-transdermal-patch-loaded-with-ascorbic-acid 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/nanoemulsion-laden-organogels-of-lidocaine-as-lipid-based-systems-for-topical-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/anti-cancer-effect-of-tuberatolide-b-in-mda-mb-231-cells-through-induction-of-ros-and-inhibition-of-stat3-pathway 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/protective-effect-of-bis-3-bromo-4-5-dihydroxybenzyl-ether-against-lps-induced-inflammatory-response-in-raw-264-7-macrophages-through-ros-mediated-erk-signaling-pathway 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/saringosterol-acetate-suppressed-hepatocelluar-carcinoma-growth-and-metastasis-in-a-zebrafish-xenograft-model 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/molecular-weight-characterization-of-sodium-carboxymethyl-cellulose-by-advance-polymer-chromatography 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/strategies-to-increase-the-passage-of-large-molecules-through-the-blood-brain-barrier 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/peptide-functionalized-nanoparticles-for-the-selective-induction-of-apoptosis-in-target-cells 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/cell-free-expression-of-a-membrane-antigen-for-vaccine-uses 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/thermoresponsive-in-situ-gelling-systems-for-ophthalmic-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/antibody-guided-discovery-of-potent-small-molecule-fusion-inhibitors-of-influenza-virus 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/targeting-liver-function-to-circumvent-neuronal-and-cardiac-dysfunctions-linked-to-hyperhomocysteinemia 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/detection-of-hidden-drug-resistance-by-the-ezmtt-assay 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/new-indications-for-fda-approved-drugs-selective-inhibition-of-the-growth-of-helicobacter-pylori-by-covalent-allosteric-regulation-of-urease 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/chimeric-antigen-receptor-car-t-cell-a-biodrug-as-cancer-therapeutic-agent 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/freshwater-sapropel-as-raw-material-in-medicine-and-pharmaceutical-production 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/p-selectin-targeted-nanocarriers-are-efficient-drug-delivery-systems-to-activated-endothelium 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/development-of-novel-leads-for-triple-negative-breast-cancer-immunotherapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/screening-of-new-peptidomimetics-based-on-kinase-inhibitory-region-of-suppressors-of-cytokine-signaling-1-as-anti-inflammatory-agents 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/novel-small-molecules-for-ppars-modulation-and-their-potential-use-for-treatment-of-metabolic-disorders 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/caloric-restriction-and-longevity 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/synactix-inc-and-academic-case-studies-of-targeted-therapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/liposomal-encapsulation-of-silver-nanoparticles-suppresses-nanoparticle-induced-ros-and-inflammation-and-induces-caspase-dependent-apoptosis 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/development-of-substances-with-biological-and-pharmacological-activity-based-on-structural-nucleus-hybrids-from-phytochemical-compounds-like-secondary-metabolites 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/aspects-of-controlled-release-dosage-forms-in-veterinary-medicine-with-emphasis-on-grdf-gastro-retentive-dosage-forms 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/the-impact-of-inspiratory-parameters-on-the-performance-of-marketed-dry-powder-inhalers-using-patients-inhalation-profiles 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/cell-penetrating-peptides-and-delivery-of-oligonucleotides 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/strategies-to-improve-drug-delivery-to-the-lungs-from-dry-powder-inhalers 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/pharmaceutical-applications-of-graphene-based-nanomaterials-in-cancer-theranostics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2019/designing-extracellular-vesicles-for-bio-camouflaged-drug-delivery-and-cell-free-regenerative-medicine 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/understanding-the-impact-of-nanoparticle-structure-on-cellular-response 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/overcoming-the-barriers-to-effective-targeted-drug-delivery-through-stem-cell-derived-nano-ghosts 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/chimeric-and-multicompartment-drug-delivery-systems-lessons-learned-and-future-perspectives 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/delivery-of-sirna-in-vivo-to-the-liver-using-redox-sensitive-and-ionizable-lipids 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/getting-health-allies-from-agriculture-enemies-plant-viruses-as-smart-nanoparticles-for-vaccine-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/the-influence-of-gut-microbiota-mediated-bile-acid-metabolism-on-the-cellular-response-to-therapeutics-at-the-intestinal-barrier 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/cyclodextrin-based-photoactive-liposomal-nanoparticles-for-tumor-targeting 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/rabinogalactan-and-glycyrrhizic-acid-as-promising-agents-for-oral-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/polyethylenimine-based-nanoparticles-decorated-with-small-molecules-mimicking-rgd-peptide-for-targeted-plasmid-dna-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/next-generation-of-drug-delivery-system-stimuli-sensitive-combination-nanopreparations 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/drug-screening-and-targeting-against-the-stem-subpopulation-of-cancer-cells 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/targeting-nanomedicine-to-the-vascular-endothelium 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/nanoparticle-delivery-of-mitochondria-associated-microrna-regulating-inflammation-in-the-central-nervous-system 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/signaling-peptides-for-brain-diseases-delivery-and-action 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/lipid-based-parenteral-depots-for-biomolecules-an-update-on-recent-work 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/the-effects-of-drug-encapsulation-into-gellan-gum-matrix-by-the-example-of-roxithromycin-naproxen-and-meloxicam-tomasz-osmalek 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/5-tiered-pre-formulation-approach-to-support-toxicology-studies 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/porous-biodegradable-particles-for-efficient-transfollicular-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/novel-rna-carbohydrate-conjugates-for-modulation-of-ldlr-and-cholesterol-by-transcriptional-silencing 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/myometrium-targeted-liposomes-for-prevention-of-preterm-labor 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/poly-vinyl-pyrrolidone-nanofibers-as-drug-delivery-of-sildenafil-citrate 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/the-reversal-of-type-2-diabetes-the-role-of-the-bile-acids 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/new-potential-nanotechnology-based-therapy-with-novel-gal-3-inhibitor-for-the-treatment-of-rheumatoid-arthritis 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/new-aerosol-treatment-for-human-nasal-cavity-through-numerical-simulation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/numerical-evaluation-of-exhalation-through-the-nose-treatment-for-eosinophilic-chronic-rhinosinusitis-using-computational-fluid-dynamics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/case-presentation-patient-with-metastatic-pancreatic-adenocarcinoma-treated-with-nanoliposomal-irinotecan-combination-therapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/nanostructured-biomaterials-and-technologies-for-bone-regeneration 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/brain-targeted-nanotherapeutics-an-enticing-journey-from-ideation-to-product-realization-vandana-b-patravale 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/investigations-on-the-cytotoxic-effect-of-gold-nanoparticles-synthesized-using-ferulic-acid-on-human-epidermoid-carcinoma-a431-cells 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/physicochemical-characterization-of-co-crystals-and-cyclodextrin-inclusion-complexes-of-bioactive-molecules 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/peptide-delivery-to-the-brain-a-novel-treatment-for-migraine 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/discovering-multiple-drug-binding-sites-and-modes-with-wrap-n-shake 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/thermoresponsive-nanocarriers-for-doxorubicin-delivery-combined-with-hyperthermia 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/in-vivo-sirna-delivery-in-whitefish-sirna-uptake-and-the-efficacy-of-gene-expression-silencing 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/unnatural-amino-acids-derived-peptidomimetics-with-potent-anti-biofilm-activity 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/poly-glycolide-caprolactone-and-poly-glycolide-caprolactone-d-l-lactide-coatings-enriched-with-ciprofloxacin-formed-on-metallic-implants 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/dual-targeted-biodegradable-micelles-for-anticancer-drug-delivery 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/plga-nanoparticles-co-delivering-mdr1-and-bcl2-sirna-for-overcoming-resistance-of-paclitaxel-and-cisplatin-in-recurrent-or-advanced-ovarian-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/non-invasive-method-for-screening-drug-penetration-in-skin-using-different-dermal-drug-delivery-systems-by-raman-microscopy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/eucommia-ulmoides-ameliorates-glucotoxicity-by-suppressing-advanced-glycation-endproducts-in-diabetic-mice-kidney 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/study-of-penetration-and-analgesic-and-antiinflamatory-effects-of-indomethacin-nanoemulsion 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/quality-evaluation-of-rifaximin-tablets-by-an-eco-friendly-spectrophotometric-method-in-the-ultraviolet-region 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/radiolabeled-drug-ligand-loaded-micelles-exploring-diagnostic-and-therapeutic-potentials-for-glioma-through-the-intranasal-route 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/the-most-sensitive-neurodevelopmental-period-for-the-effects-of-methamphetamine-on-creating-predisposition-to-drug-addiction-in-adulthood 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/challenges-of-in-vitro-drug-release-testing-in-case-of-advanced-mucosal-formulations 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/hea-hema-hydrogels-composition-effect-on-physicochemical-and-pharmaceutical-properties 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/cyclic-gmp-amp-a-new-hope-for-metabolic-disease 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/computational-blind-docking-of-ligands-to-drug-targets-methodology-and-applications 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/the-competitive-binding-studies-of-cmp-inhibitor-and-polysialic-acid-polysia-to-the-polybasic-polysialyltransferase-domain-pstd-in-the-polysialyltransferase 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/the-main-trends-in-the-developing-novel-therapeutics-for-alzheimer-s-disease-treatment 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/casein-based-nanovehicles-for-oral-delivery-of-chemotherapeutic-combinations-to-overcome-multidrug-resistance-in-gastric-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/use-of-an-inflating-agent-to-engineer-novel-lactose-carrier-for-inhalation-and-drug-deposition-in-vitro-using-three-model-drugs-salbutamol-beclomethasone-and-fluticasone 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/characterization-of-lactose-carrier-for-dry-powder-inhaler-formulations 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/eaat3-proteins-as-a-pharmacological-target-for-the-design-of-new-antiepileptic-drugs 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/hard-alginate-capsules-shell-as-enteric-capsules 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/synthesis-and-cytotoxicity-studies-on-novel-piperazinylacetamides 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/stability-studies-on-the-formulations-of-inclusion-complex-of-tenoxicam-in-sbe7-cyclodextrin-and-beta-cyclodextrin 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/development-and-evaluation-of-self-micro-emulsifying-drug-delivery-systems-of-itraconazole 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/microbiological-pharmaceutical-analysis-better-safe-than-sorry 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/nature-of-naproxen-enantiomers-medicinal-activity-difference-study-by-using-model-systems-and-modern-physical-methods 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/nanoparticles-in-receptor-mediated-drug-delivery-to-brain-parenchyma 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/methotrexate-induced-liver-and-renal-toxicity-management-by-cornus-mas-back-to-nature-antioxidants-in-fighting-drug-side-effects 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/impact-of-inhalation-manoeuvre-parameters-on-drug-delivery-to-the-lungs-from-dry-powder-inhalers-in-vitro-and-ex-vivo 0.8 https://pharmaceuticsconference.com/program/scientific-program/2018/flexible-analyses-of-population-based-pharmaco-epidemiological-studies-of-comparative-effectiveness-and-safety-of-drugs 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/targeted-self-navigating-multifunctional-drug-delivery-vehicles-driven-by-promiscuous-landscape-phage-proteins 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/nucleic-acid-based-amphiphiles-as-soft-materials-for-nanomedicine 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/patient-centric-dug-delivery-systems-odt-oral-disintegrating-tablet-and-odf-oral-disintegrating-film 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/formulation-of-liposomal-doxorubicin-modified-with-bombesin-peptide-for-selective-targeting-of-grp-receptors-over-expressed-by-cancer-cells 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/development-of-receptor-targeted-nanocomplexes-for-delivery-of-rna-therapeutics-to-the-lung 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/drug-delivery-across-the-skin-barrier-using-biocompatible-thermoresponsive-nanogels 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/engineering-endosomal-escape-using-phlexi-particles 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/aptamers-as-therapeutic-agents-in-human-cancers-and-evidence-for-glioblastoma-targeting-through-the-blood-brain-barrier-of-aptamer-functionalized-nanosystems 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/building-a-better-antibody-based-medicine-antibody-mimetic 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/oral-delivery-of-lipophilic-drugs-the-solubility-permeability-interplay-and-formulation-design 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/inhalable-therapy-of-pulmonary-tuberculosis-mediated-by-polysaccharide-microparticles 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/macrophage-stabilized-drug-crystals 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/engineered-spatiotemporal-delivery-of-morphogens-for-skeletal-regeneration 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/transfection-by-cell-penetrating-peptides 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/bioinspired-sequence-defined-drug-protein-and-gene-carriers-by-chemical-evolution 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/challenge-and-progress-in-delivering-molecules-to-the-brain 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/lipoprotein-based-drug-delivery-platform 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/impact-of-surface-anisotropic-forces-on-powder-flowability 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/novel-ring-fused-tetrapyrrolic-macrocycles-as-very-active-photodynamic-agents-for-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/ex-vivo-intraocular-model-to-investigate-long-term-protein-stability-in-vitreous-humor 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/development-of-microparticles-loaded-with-pine-bark-extracts-and-evaluation-of-its-bioavailability-on-fish 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/can-antibiotics-treat-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/peptide-based-therapeutics-for-the-treatment-of-neurodegenerative-diseases-challenges-and-opportunities 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/polymer-based-combination-therapeutics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/hydrogen-sulfide-a-novel-mediator-and-therapeutic-target-for-inflammatory-disease 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/locust-bean-gum-based-nanoparticles-for-oral-immunization 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/active-loading-of-resveratrol-in-transferrin-functionalised-liposomes-using-a-ph-gradient-technique 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/understanding-intestinal-permeability-the-effect-of-intestine-complexity-on-oral-drug-absorption 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/driving-endocytosis-for-enhancing-cellular-delivery-and-intracellular-targeting-of-therapeutics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/cyclodextrins-as-reliable-solubilizationtools-for-bcs-class-ii-and-iv-drugs 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/dry-powder-inhalers-challenges-and-opportunities-in-delivering-drugs-to-the-lungs 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/crystal-engineering-of-alternative-solid-forms-of-therapeutic-agents 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/anionophores-an-emerging-group-of-molecules-to-fight-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/oral-delivery-of-a-novel-antibody-domain-vorabody-for-the-treatment-of-crohn-s-disease 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/sustained-and-or-controlled-delivery-by-core-shell-polymer-nanocapsules 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/development-and-evaluation-of-nanofibrous-oral-strips-new-drug-delivery-system-for-poorly-soluble-drugs 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/absorption-enhancing-capacity-of-dissolving-microneedle-arrayed-patches 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/the-effect-of-the-inhalation-manoeuvre-parameters-on-the-indacaterol-drug-deposition-from-onbrezbreezhaler-dry-powder-inhaler 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/the-applications-of-potential-aromatic-prodrugs-in-ntr-based-cancer-therapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/method-indicative-of-stability-for-determination-of-rifaximin-and-its-degradation-products-by-thin-chromatographic 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/a-pre-formulation-study-of-recombinant-human-interleukins-1-receptor-antagonist-for-emergency-use 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/polyphenols-loaded-vaginal-microbicide-a-novel-strategy-for-prevention-of-hiv-transmission 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/design-and-synthesis-of-new-ef2k-inhibitors-for-the-treatment-of-tnbc-and-pancreatic-cancers-and-their-in-vitro-release-studies-from-biocompatible-natural-polymeric-particles 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/nanoparticle-engineering-of-atovaquone-using-nano-by-design-nbd-approach 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/analytical-method-development-and-validation-of-end-laa-for-in-vitro-and-in-vivo-studies 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/inn-darunavir-patenting-problem-of-active-pharmaceutical-substances 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/preclinical-development-of-gmc1-a-novel-molecule-targeting-fkbp52-for-the-treatment-of-castration-resistance-prostate-cancer 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/development-of-formulations-for-novel-chemotherapeutic-agents-for-tuberculosis-and-hiv-coinfection 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/steroid-estrogen-analogues-as-potential-drugs-with-targeted-action 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/the-bone-cartilage-interface-a-complex-biological-barrier-with-potential-therapeutical-targets 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/improvements-of-computational-optimization-of-drug-target-interactions 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/towards-improved-activity-and-stability-of-gene-therapeutics 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/smart-lipid-nanocarriers-potential-for-intracellular-targeting 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/potentiation-of-cytotoxic-action-of-the-new-cisplatin-derivative-by-uv-irradiation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/impact-of-gut-microbiota-mediated-bile-acid-metabolism-on-the-solubilization-capacity-of-bile-salt-micelles-and-drug-biopharmaceutical-properties 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/development-of-intravenous-form-of-rifapentine-and-its-in-vivo-evaluation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/green-technology-approach-for-development-of-bcs-class-ii-molecule-nanoformulation 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/nanocomposite-microparticles-for-the-pulmonary-delivery-of-bio-macromolecules 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/development-of-nitroreductase-prodrug-system-for-cancer-therapy 0.8 https://pharmaceuticsconference.com/program/scientific-program/2017/comparison-of-uv-ir-ce-hplc-and-turbidimetric-methods-in-the-evaluation-of-rifaximin 0.8 https://pharmaceuticsconference.com/program/scientific-sessions/novel-developments-in-drug-delivery-system 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/cellular-targeting-and-intracellular-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-microbiology-and-biotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/formulation-technologies 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-product-development-and-manufacturing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/advanced-drug-delivery-systems 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/vaccine-design-and-drug-delivery-technology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacovigilance-and-drug-safety 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacogenomics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/therapeutic-drug-carrier-systems 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/regulatory-affairs-and-intellectual-property-rights 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanotechnology-in-pharmaceutics-and-drug-delivery-systems 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-and-medical-case-reports 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-analysis 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/personalized-and-precision-medicine 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-discovery-and-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/research-and-development-r-d 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-trials 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/quality-control-qc-and-quality-assurance-qa 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/packaging-and-labeling 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-marketing-and-management 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacology-toxicology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/bioavailability-and-bioequivalence-studies 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biostatistics-and-data-management 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biodrugs-and-biotherapeutics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-delivery-routes-and-challenges 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacokinetics-pharmacodynamics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/role-of-pharmaceutics-in-global-health 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/emerging-technologies-in-pharma 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/ai-and-machine-learning-in-drug-development-and-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/advances-in-pharmaceutical-sciences 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-research-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-discovery-and-screening 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/preformulation-studies 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biotherapy-and-radiopharmaceuticals 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biodrugs-biomolecules-and-therapeutics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/inhaled-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-analysis-and-quality-assurance 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/peptides-and-protein-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/impact-of-covid-19-on-pharmaceutical-industry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-delivery-through-bbb 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/advances-in-biotherapeutics-drug-discovery-and-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-discovery-strategies-to-fight-covid-19 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/covid-19-vaccine-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacologic-treatments-for-covid-19 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/covid-19-drug-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/covid-19-drug-delivery-system 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/current-therapeutic-drugs-treating-covid-19 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/covid-19-impact-on-world-wide-pharma-companies 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/precision-personalized-medicine-and-specialty-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/personalised-medicine 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/specialty-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-abuse 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-technology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/radiochemistry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/adverse-drug-reactions 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-discovery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceuticals 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacokinetics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biotherapy 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-design 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-research 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-biotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacodynamics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacovigilance 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-safety 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-metabolism 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/protein-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-screening 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/personalized-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/industrial-pharmacy 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biotherapeutics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/peptide-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-targeting 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/radiopharmaceuticals 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-industry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/physical-pharmacy 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/intracellular-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-organic-chemistry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/cellular-drug-targeting 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacokinetic-studies 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nano-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-delivery-technology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-manufacturing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/speciality-pharmacy 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-toxicity 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-quality-control 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-delivery-vehicles 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-designing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-quality-assurance 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biosimilar-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-product-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/targeted-drug-delivery-system 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-delivery-devices 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-safety-monitoring 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/cellular-targeting-of-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/formulation-screening 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-solubility 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/lyophilization 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-drying-technique 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-packaging 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-delivery-system 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/routes-of-drug-administration 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/solubility-analysis 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/stability-analysis 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/compatibility-studies 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/active-pharmaceutical-ingredients 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/organoleptic-characters 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/aerosol 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacogenetics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/peptide-formulation-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/oral-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/formulation-of-covid-vaccine 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biomaterials-in-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/regulatory-inspections 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/formulation-of-nanoparticles 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biosensor-devices 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/radiolabelled-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/molecular-imaging 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/hybrid-imaging-in-diagnosis 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/radioactive-tracers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacometrics-in-drug-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/kinetics-of-drug-disposition 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/computer-aided-drug-design-cadd 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/computational-biology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/conformational-analysis-and-activity-profiling 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/3d-pharmacophores 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-interaction 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/synthetic-pharmaceutical-chemistry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/preventing-adverse-drug-reactions 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/fatal-adr-s 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/dose-related-adrs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/allergic-adrs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/idiosyncratic-adrs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/revolutionizing-healthcare 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/advanced-clinical-research 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/analysis-of-potential-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/bioavailability 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/bioequivalence 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biomedical-engineering 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biopharmaceutical-research 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-designing-chemistry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-formulations 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/injectable-drug-devices 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/medical-devices 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/medicinal-plants 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/orphan-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/parenteral-packaging 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-drug-testing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/novel-drug-delivery-systems 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/polymer-drug-delivery-systems 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/cns-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/respiratory-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/non-viral-rna-delivery-systems 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/transdermal-and-microneedle-drug-delivery-systems 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/injectable-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/opthalamic-drug-delivery-systems 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/controlled-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/carbon-based-nanomaterials-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/mucoahesive-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/lipid-based-drug-delivery-systems 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/mucosal-drug-delivery-system 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/thin-film-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/magnetic-film-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/animal-biotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/applied-pharmaceuticals 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biomedical-sciences 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biopharmaceutical-manufacturing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biopharmaceutics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/analytical-biotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/industrial-microbiology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/applied-biology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/innovation-in-pharmaceutical-sciences 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/bioinformatics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/medicinal-chemistry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanomedicine 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanopharmaceutics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biopharmaceuticals 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-and-healthcare-marketing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/fermentation-technology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-care 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-chemistry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-compounding 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-drug-delivery 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-drug-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-education-and-practice 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-engineering 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-ethics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/bioprocess-engineering 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-formulation 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/cancer-biology-and-therapeutics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-health-policies 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-labelling 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-research 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-manufacturing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/digital-biomarkers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/absorption-distribution-metabolism-and-elimination-adme 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-microbiology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-nanotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-repurposing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/bioavailability-and-bioequivalence 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-oncology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biochemical-pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-preformulation 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-regulatory-affairs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/chronopharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/environmental-biotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-testing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-toxicology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-drug-investigation 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/epigenetics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceuticals-and-clinical-research 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-psychopharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacological-and-pharmaceutical-sciences 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/recombinant-pharmaceuticals 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/food-biotechnology-and-processing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/synthetic-chemistry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/genetic-engineering 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/genetics-and-molecular-biology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/medical-biotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/microbial-biotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/molecular-biotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nano-biotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-therapeutics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/plant-based-biopharmaceuticals 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-toxicology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/preventive-medicine 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/synthetic-biotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-absorption 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-formulation 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/translational-medicine 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-resistant-pathogen 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/geriatric-pharmacotherapy 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/immunopharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/in-silico-drug-discovery-and-development 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/in-silico-modeling 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/neuropharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/personalized-therapy 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacoepidemiology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacokinetic-evaluation-in-pregnancy 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacoproteomics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacotherapeutics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/plasma-protein-binding 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/predictive-toxicology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/systems-pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/toxicokinetics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/anti-cancer-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/antibody-drug-conjugate 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/bioceramics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biochemistry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biocompatibility 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/bioequivalence-studies 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biological-barriers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biologics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biopharmaceutical-classification-system 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biosimilars 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biowaivers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/cheminformatics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/dna-synthesis 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-interactions 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-regulatory-affairs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-regulatory-harmonization 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-substance 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/excipients 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/fluid-phase-equilibria 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/food-and-drug-administration 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/generic-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/in-vitro-models 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/intramuscular-injection 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/isoelectric-focusing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/liposome 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/lyophilisation 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/molecular-pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/multi-drug-resistance 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nucleic-acid-drugs 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacognosy 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacological-stimulation 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacoresistance 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/prodrug 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/serotonin-pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/toxicodynamics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/active-pharmaceutical-ingredient 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biopharmaceutical-sciences 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/cardiovascular-pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/cholinergic-drugs-and-pharmacodynamics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-pharmacokinetics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-issues 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-toxicology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/ecopharmacovigilance 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/forensic-toxicology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/neuro-pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/ocular-pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacometrics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacophore 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/physiologically-based-pharmacokinetic-modeling 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/psychopharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pulmonary-pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/safety-pharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/applied-nanoscience 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/applied-nanotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biomedical-nanotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biopolymers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/carbon-nanotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/carbon-nanotubes 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/controlled-release 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/molecular-nanotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nano-chemistry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nano-crystalline-semiconductors 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nano-energy 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nano-engineering 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nano-sensors 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanoanalysis 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanobiotechnology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanocharacterization 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanochemistry 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanodevices 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanoelectronics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanofabrication 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanomanufacturing 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanomaterials 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanometrology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanopharmacology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanophotonics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanophysics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanoplastics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanorobotics 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanosafety 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanotechnology-in-diagnosis 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanotoxicology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/anesthesia-and-clinical-research 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biomarkers-in-clinical-trials 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-epidemiology 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-trials-and-therapeutic-drug-monitoring 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-trials-in-rare-diseases 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/medical-imaging-and-clinical-research 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/oncology-clinical-trials 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/patient-centric-clinical-trials 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/preclinical-research 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/randomisation-in-clinical-trials 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-scientists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacologists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutics-experts 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-formulation-scientists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/nanomedicine-specialists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biopharmaceutical-scientists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-discovery-and-development-researchers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/preclinical-and-clinical-researchers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/medicinal-chemists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-biotechnology-experts 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacokinetics-and-pharmacodynamics-specialists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-safety-experts 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-delivery-scientists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/quality-control-and-quality-assurance-experts 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-industry-consultants 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-engineers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/process-development-scientists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-pharmacists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/hospital-pharmacists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacovigilance-experts 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-data-scientists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-material-scientists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/gene-and-cell-therapy-scientists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/peptide-and-protein-drug-delivery-specialists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/formulation-scientist 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-discovery-scientist 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/preclinical-research-scientist 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/toxicologist 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/analytical-scientist 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-production-manager 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/quality-control-analyst 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/qc-microbiologist 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/qa-validation-specialist 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-regulatory-specialist 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmacovigilance-officer 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/medical-safety-officer 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-trial-coordinator 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-data-manager 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/medical-writer 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharma-marketing-manager 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharma-sales-representative 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-nanotechnology-experts 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-process-engineers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutics-product-development-scientists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biomaterials-researchers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/drug-formulation-technologists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/liposome-drug-delivery-experts 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/biomolecular-drug-delivery-engineers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-packaging-engineers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-manufacturing-technologists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-computational-chemists 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-toxicology-experts 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/gene-delivery-systems-researchers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/microencapsulation-experts 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-biotechnology-product-managers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/immunopharmaceutical-researchers 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-manufacturing-quality-experts 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/pharmaceutical-clinical-research-associates-cra 0.9 https://pharmaceuticsconference.com/program/scientific-sessions/clinical-research-pharmacists 0.9 https://pharmaceuticsconference.com/uploads/pdfs/tentative-program.pdf 0.8 https://pharmaceuticsconference.com/uploads/pdfs/initial-announcement.pdf 0.8 https://pharmaceuticsconference.com/uploads/pdfs/final-program.pdf 0.8 https://pharmaceuticsconference.com/uploads/pdfs/abstract-submission-sample.docx 0.8 https://pharmaceuticsconference.com/uploads/pdfs/conference-brochure.pdf 0.8 https://pharmaceuticsconference.com/uploads/pdfs/sponsors-exhibitors.pdf 0.8 https://pharmaceuticsconference.com/2025 0.8 https://cloud.magnusgroup.online/pdds/book/pdf/pdds-2025.pdf 0.8 https://cloud.magnusgroup.online/pdds/program/pdf/pdds-2025.pdf 0.8 https://pharmaceuticsconference.com/2024 0.8 https://cloud.magnusgroup.online/pdds/book/pdf/pdds-2024.pdf 0.8 https://cloud.magnusgroup.online/pdds/program/pdf/pdds-2024.pdf 0.8 https://pharmaceuticsconference.com/2023 0.8 https://cloud.magnusgroup.online/pdds/book/pdf/pdds-2023.pdf 0.8 https://cloud.magnusgroup.online/pdds/program/pdf/pdds-2023.pdf 0.8 https://pharmaceuticsconference.com/2022 0.8 https://cloud.magnusgroup.online/pdds/book/pdf/pdds-2022.pdf 0.8 https://cloud.magnusgroup.online/pdds/program/pdf/pdds-2022.pdf 0.8 https://pharmaceuticsconference.com/2021 0.8 https://cloud.magnusgroup.online/pdds/book/pdf/pdds-2021.pdf 0.8 https://cloud.magnusgroup.online/pdds/program/pdf/pdds-2021.pdf 0.8 https://pharmaceuticsconference.com/2020 0.8 https://cloud.magnusgroup.online/pdds/book/pdf/pdds-2020.pdf 0.8 https://cloud.magnusgroup.online/pdds/program/pdf/pdds-2020.pdf 0.8 https://pharmaceuticsconference.com/2019 0.8 https://cloud.magnusgroup.online/pdds/book/pdf/pdds-2019.pdf 0.8 https://cloud.magnusgroup.online/pdds/program/pdf/pdds-2019.pdf 0.8 https://pharmaceuticsconference.com/2018 0.8 https://cloud.magnusgroup.online/pdds/book/pdf/pdds-2018.pdf 0.8 https://cloud.magnusgroup.online/pdds/program/pdf/pdds-2018.pdf 0.8 https://pharmaceuticsconference.com/2017 0.8 https://cloud.magnusgroup.online/pdds/book/pdf/pdds-2017.pdf 0.8 https://cloud.magnusgroup.online/pdds/program/pdf/pdds-2017.pdf 0.8